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Abstract
An estimate (both quantitative and qualitative) of the level of risk of death a
patient has after being diagnosed with bladder cancer (BCa) is often benefi-
cial to both the clinician and the patient. The estimate can help to investigate
the effects of different therapies on this risk level thereby aiding risk manage-
ment decisions. The estimate can also help the patients plan their lives as well
as to understand the specific lifestyle changes needed to lower the risk. But
estimating this risk is often very difficult because of factors such as censor-
ing, high dimensionality and evolving treatments during follow ups as well as
erratic disease behaviour. Traditional artificial intelligence techniques do not
handle these challenges adequately whilst allowing for the integration of the
vast amount of expert knowledge in BCa management. This thesis addresses
these concerns and challenges by proposing efficient methods to elicit fuzzy
models from data which will allow one to better handle these complexities
xiv
Abstract
with a view to more accurate and interpretable predictions.
Fuzzy logic technology is investigated throughout because fuzzy models
are relatively transparent and, as humans, can relate to and as a result would
facilitate their adoption by clinicians and oncologists. To handle the problem
of censoring, the thesis integrates the proposed fuzzy models with the well-
known Cox model. This would allow one to take advantage of the mature
field of survival analysis (a branch of statistics) and fuzzy modelling so that
the mathematical convenience and simplicity of the original Cox modelling
framework is exploited.
It is widely understood that relapse from cancer completely changes the
disease prognosis so that the ‘static’ model predictions on initial diagnosis be-
come grossly inaccurate. The thesis also investigates how this dynamic infor-
mation (relapse from BCa) can be incorporated into the modelling framework.
Results suggest that the proposed modelling frameworks successfully han-
dle these challenges efficiently and elegantly and lead to better performances
than the traditional artificial intelligence and survival analysis methods.
xv
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1.1 Research Background and Motivation
A number of questions immediately come to the minds of both the patient
and the clinicians when the patient is diagnosed with bladder cancer (BCa).
Is the cancer invasive or not? Is the patient of low or high risk? What type
of therapy would lower this risk? What is the likelihood of a relapse from the
disease during follow-up? Essentially, it is of interest to know how the dis-
ease would behave and respond to the many possible, different and dynamic
therapies (and perhaps changes in lifestyle1) during follow-ups. Answering
these questions would allow the clinicians to decide on the BCa management
1A patient smoker may decide to quit smoking on being diagnosed with BCa.
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pathway [1].
Traditionally, an estimate of the risk on diagnosis with BCa and treat-
ment options are usually derived from a combination of the clinicians prior
experience and standard staging mechanisms (for example the Tumour-Node-
Metastasis (TNM) staging) [1]. However, this approach can often return mis-
leading conclusions with many patients diagnosed as having aggressive can-
cers (e.g. T4, N3, M1 in the TNM staging mechanism) beating the odds and
living well beyond the clinicians’ expectation and vice versa.
The advent of fast and relatively cheap computing and storage platforms
have provided opportunities for keeping track of patients’ and disease infor-
mation during the course of follow-ups. These data, if adequately analysed,
can provide vital clues and information from which useful conclusions can be
drawn to help clinicians and patients better understand the likely course of
the disease. BCa is one of the most common cancers2 and arguably the most
expensive to manage [1] because it is a recurring and relapsing disease re-
quiring several courses of treatments thus requiring long term surveillance of
the bladder. Gleaning out useful information from a BCa database can lead to
significant cost savings as well help prevent the harmful side-effects of aggres-
sive therapies (such as chemotherapy and radiotherapy) which are not often
2fourth most common in UK men and 11th most common in UK women [2]
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needed. Such models would allow for investigating and visualising before-
hand different hypothetical scenarios (such as the likely effects of different
treatment types), thus allowing for a more dynamic and targeted therapy, in
itself a detour from the usual generic (and usually static) treatment adminis-
tered to patient sub-groups.
The wealth of experience that clinicians have gained over the many years
of managing BCa should, however, not be discounted. Good insights may
often be derived from this so called expert knowledge which are capable of
integration with information gained from the BCa database. Not only would
this allow for more robust prediction models but also for facilitating the adop-
tion of such models by clinicians since such models tend to be transparent and
easy to relate to [3].
Eliciting prediction models can be very challenging because of the pecu-
liarities of a BCa database coupled with the limitations associated with exist-
ing machine learning algorithms. Typically, BCa databases contain noisy vari-
ables and censored3 observations and include high dimensionality with un-
observed or dynamic variables [4]. It is not unusual to find that, in a dataset,
patients can have identical values of covariates but may surprisingly also have
completely different event times. It may be that risk of death for the two pa-
3Censoring is a type of missing variable problem where the response variable is not known
exactly.
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tients is dependent on a covariate not measured at the time of data collection.
Additionally, the BCa’s possible course is diverse, as shown in Fig. 1.1.and is
not a straightforward one-end-point disease.






Figure 1.1: Bladder cancer may behave in a variety of ways as shown in this
figure. Each line represents the possible course of behaviour after treatment.
The cancer grade tells how much different the cancer cells are to normal cells.
High grade BCa tends to grow faster and is more likely to be invasive. This is
explained in greater detail in Chapter 2.
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Existing machine learning technologies do not adequately manage these
difficulties as well as allow for incorporation of both dynamic and expert in-
formation.
This project provides a dynamic risk-model of patients diagnosed with
BCa. The elicited models are capable of handling the highlighted peculiar-
ities of a BCa database. The mapping (or model) provides both qualitative
and quantitative risk estimates for a new patient diagnosed with BCa and al-
lows for incorporating patients’ dynamic information relating, for example, to
a relapse from BCa during follow up.
The developed algorithms will allow for maximum usage of the limited
available information and will result in models which are open to scrutiny
and available for usage by clinicians at different time points during follow-up
periods .
Treatments administered (if any) on patients have been included in the de-
sign of the models. This allows for investigating the effect of these treatments
and how they affect the risk of the patient.
This is a collaborative project between the Royal Hallamshire Hospital4
and the Intelligent Systems Laboratory (ISL) of the Department of Automatic
Control & Systems Engineering (ACSE), the University of Sheffield, United
4Sole provider of urological services in the city of Sheffield, United Kingdom.
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Kingdom (UK). To determine and understand long term consequence of BCa
patients, the hospital created a database of all BCa patients for 16 years be-
tween 1 January 1994 and 31 December 2009. This database is analysed
extensively in Chapters 5 and 6.
1.1.1 Motivation
Previous and current studies on the BCa database have focussed on under-
standing the data using non-parametric competing risk analysis (see [5] for
details). Specifically, the data were stratified into 12 patient groups based
on age group, sex of patients and competing mortality risk analysis performed
based on the cumulative incidence function (CIF) method developed by Scrucca
in [6] to these strata in order to identify the risk groups of these strata.The
study concludes that older patients tended to have higher cancer specific mor-
tality (CSM) meaning that they tend to die sooner from BCa. Worse outcomes
were reported for female patients but the study concludes that further investi-
gations are needed to ascertain why this is the case. The major criticisms with
this approach are:
• Although approximately 12 covariates were recorded for each pa-
tient at presentation with BCa the study stratifies on only 3 of
these covariates: tumour group, age and sex. The other covari-
6
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ates were neglected and there was no adequate accounting for
the varying treatments administered to patients on diagnosis with
BCa. The obvious criticism centres around not including the other
covariates in the analysis. The more salient criticism involves
the fact the stratification does not allow for personalised analy-
sis since the patients have been grouped and variations within
groups not adequately catered for.
• The second major criticism is that the study does not account for
the dynamics of the study. For example, intermediate events such
as relapse from BCa were not adequately accounted for when find-
ing the Other Cause Mortality (OCM) and Disease Specific Mor-
tality (DSM). As illustrated in [7], these intermediate events can
considerably change the risks of a patient during follow-up and it
would be beneficial to both clinicians and patient to understand
such changes.
This project addresses these concerns and accounts for the heterogeneity of
the patients in the database thus allowing for better personalised prognosis,
treatment and subdivision into risk groups. To allow for models that are truly
interpretable, accurate and systematic, the elicited models incorporate a new
type-2 fuzzy logic modelling approach synergistically combined with matured
7
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survival data techniques to result in a powerful risk grouping algorithm. And
because treatments (if any) administered to patients on presentation with BCa
are fed back as inputs to the model, the elicited model can help clinicians
investigate which particular treatment would lower the patient’s risk of death
from BCa.
1.1.2 Aims and Objectives
This research aims at finding an interpretable and accurate dynamic predictive
risk map for patients diagnosed with BCa. The steps by which this is achieved
in this research are as follows:
1. The research will develop a new transparent survival analysis frame-
work to understand the risk of death from BCa which takes into
account missing variables (such as censoring) and complex non-
linear interaction amongst the covariates/input variables. The
proposed framework will integrate interval type-2 fuzzy modelling
with survival analysis in a synergistic manner to exploit the strengths
of both modelling paradigms.
2. The research develops a competing risk analysis modelling frame-
work to understand the effects of competing events (death from
other causes) on the estimated quantitative risk.
8
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3. The research proposes a transparent framework to extend the
above modelling frameworks so that a patient’s dynamic informa-
tion can be used to add knowledge from the database to achieve
dynamic risk prediction. This is necessary because BCa may evolve
and patients will move into different states during follow-up.
4. The research proposes a framework for uncertainty management
and quantification in the form of a Bayesian approach modelling.
1.2 Overview of Thesis
The thesis is organised as follows: Chapter 1 provides a background motiva-
tion for the research project. It discusses the aims and objectives of the project
and concludes with a summary of contributions made to existing knowledge
in the course of carrying out the research project.
Chapter 2 provides a synopsis of what BCa is, treatment options and pro-
vides a literature survey of techniques in the literature for BCa prognosis using
data-modelling approaches.
Chapter 3 introduces the theory of fuzzy logic. Fuzzy logic is considered
in this research as it is able to model very complex systems using easy to un-
derstand human-like if-then rules. This is a natural way to accomplish the
9
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goal of developing a transparent and accurate risk maps of BCa patients. To
handle linguistic uncertainties in the modelling process. Higher order fuzzy
logic called type-2 fuzzy logic is considered. The chapter concludes by propos-
ing a new framework for interval type-2 fuzzy modelling elicitation which is
computationally efficient and allows for the systematic determination of both
antecedent and consequent parameters of the fuzzy logic system.
Chapter 4 incorporates the Bayesian reasoning into the type-2 fuzzy mod-
elling. As will be explained in the chapter, the elicited model is capable of
providing a degree of confidence in the predictions as determined by both the
random uncertainties and linguistic uncertainties embedded in the modelling
process. Additionally, the chapter discusses a new representation for fuzzy sets
which facilitates the incorporation of the Bayesian and fuzzy reasoning. The
proposed framework is tested on a challenging real-life engineering problem.
Chapter 5 explains how survival analysis techniques particularly lend them-
selves well to handle noisy and complex cancer data. The survival analysis
theory is mature and dates back to the early 1960’s when data were restricted
to few data points and limited computational power. The advent of fast com-
puting and storage platforms provide opportunities for making use of com-
plex modelling frameworks (such as those developed in this chapter) so that
maximum information can be extracted from data. The chapter discusses the
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relevant theory of survival analysis and presents a transparent predictive risk
modelling framework. The chapter also provides extensive analyses of the
BCa database used in the research.
Chapter 6 extends Chapter 5 by allowing elicited models to incorporate
patients’ dynamic information. The proposed framework is based on a new
type of interval type-2 fuzzy multistate modelling approach. The chapter also
presents extensive analysis of the results from testing of the proposed frame-
work on the BCa database.
1.2.1 Summary of Contributions
The summary of contribution is discussed as follows:
1. A systematic and computationally efficient framework for interval
type fuzzy model elicitation is developed and discussed in chapter
3.
2. The Bayesian reasoning is hybridised with interval type-2 fuzzy
modelling so that the resulting framework can manage linguistic
and random uncertainties inherent in both the data and the mod-
elling process.
3. A model (hybrid of survival data and fuzzy modelling) to deter-
11
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mine the risk of a BCa patient is elicited. The model also allows
for risk management decisions since it allows to investigate how
different therapies affect these risks.
4. A dynamic risk model capable of incorporating new information
in a bid to improve modelling accuracy is elicited.
12
Chapter 2
A Review of Risk Modelling in
Bladder Cancer
2.1 Introduction
This chapter reviews the literature on existing data-modelling techniques for
understanding cancer. The chapter begins by providing a brief introduction to
cancer and defines relevant cancer terms which facilitate understanding sub-
sequent chapters. Existing approaches for eliciting risk models from a cancer
database are discussed extensively paying particular attention to bladder can-
cer (BCa) models. How uncertainties (both random and linguistic) make the
modelling problem very challenging and how existing techniques may not be
13
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tenable in addressing these challenges are discussed. The concluding parts of
this chapter propose and provide the ‘rationale’ for the new modelling frame-
works elicited in the remaining parts of the thesis which are able to handle
the peculiarities of BCa risk modelling problem.
2.2 Carcinogenesis or the origin of cancer
Cells are fundamental building blocks of life and are created when an old
cell divides into two or two cells fuse together (as do sperm cells with eggs).
Every cell has a life cycle. During the life cycle, the living cells may divide
and make more cells (mitosis and meiosis), go into inactive state (replicative
senescence) or the cells may simply die (apoptosis) [8].
Cancer1 begins when an individual’s2 normal cells deviate from their planned
and systematic life cycle (apoptosis) to follow their own proliferation se-
quence. All cells produced from these abnormal cells inherit this abnormality.
Consequently, what follows is a mass of abnormal cells called a tumour which
may remain in the original tissue (called in-situ cancer) or may invade neigh-
bouring tissues (called invasion) or spread in order to attack parts and organs
1Cancer derives its name more than 2300 years ago when Hippocrates observed the surfaces
of some cut solid malignant breast tumours resembles a crab. From this observation came its
name Carcinoma/Carcinos (Greek word for crab) which was translated to Latin by Celsius into
CANCER [9].
2It is now clear that cancer cells arise from the body’s own tissue and are not due to foreign
tissues introduced to the patient’s body by say an infection.
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of the body (called metastasis3). Tumours which are able to metastasise are
called malignant tumours. The stages of tumour development is a multi-step
process called tumourigenesis and is described as follows:
1. Genetic damage causes successive mutations in a cell’s deoxyri-
bonucleic acid (DNA). These mutations alter key cellular functions
such as suppressing programmed cell deaths or increasing cell di-
vision potentially leading to a cancerous cell 4. These damages
mainly result from an exposure to carcinogens (called somatic
mutations) or inherited mutated versions (from the germline 5)
of some genes and this results in the so-called familial tumours.
2. These altered cells and their progenies grow and divide rapidly (a
condition called hyperplasia).
3. Continuous division of the abnormal cell’s progenies to form a
tumour (called dysplasia).
4. These tumours are called in-situ tumours at first because the tu-
mour resides in the same tissue the abnormal cells started to grow
3Metastasis refers to the ability of cancerous cells to invade lymph nodes and use blood
vessels as highways to spread to parts of the body to invade normal tissues of organs completely
different from where the cancer originate.
4For example, some cancers result from decreased apoptosis which means a mass of cell
develops overtime.
5Germline mutation refers to inheritable mutations in the germ cells. The germ cells are
cells destined to become sperm/egg or zygote (at the single cell stage)
15
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Figure 2.1: Normal Vs. Cancerous Cell Divisions. As can be seen, cancer-
ous cells deviate from normal cells’ programmed cell death (apoptosis) which
results in proliferation of these (abnormal) cells [10].
16
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in. Though this tumour may remain contained indefinitely in the
same tissue, it is not unusual for tumours to invade other nearby
tissues.
5. Some of these abnormal cells undergo even more mutations to be-
come malignant which allow them to invade other tissues, lymph
nodes and pass through the blood stream to invade, settle, attack
and form more tumours in completely different organs and sys-
tems of the body. For example, Lymphatic spread of BCa involves
infiltration of the para-ortic and ilac lymph nodes with the spread
involving vital organs such as the lung, liver and adrenal gland.
The cancer is said to have metastasised. Metastasised cancers are
the most dangerous and carry the worst prognosis!
It has also been observed that nearly all cancers are monoclonal in nature
i.e. the cancerous masses have resulted from a single abnormally mutated
cell. This means that the cancerous masses or tumours are descendants of
a single ancestral cell which underwent the unfortunate mutation. Only a
small percentage is poly-clonal where the resulting cancerous tumours have
resulted from two or more abnormally mutated cells.
17
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2.2.1 Bladder Cancer - Epidemiology and Aetiology
The bladder is part of the urinary tract and is a hollow muscular organ which
stores urine. It has four main walls: inner lining called the urothelium/epithelium,
followed by the lamina propria which is a thin layer of connected tissues,
nerves and blood vessels. The next layer is a mass of muscle called the mus-
cularis propria. The last layer is the fatty tissue mass which divides the bladder
from other organs of the body [5], see Fig. 2.2.
95% of all (BCas) are carcinomas6 (Urothelial Cell Carcinoma (UCC))
meaning they develop from the epithelial 7 cells [12] i.e. BCa typically starts
from the urothelium.
BCa is one of the most common cancers and arguably the most difficult
to diagnose and expensive to treat [12]. About 380 000 (≈ 3% of all can-
cers) new cases were recorded worldwide in 2008 [1]. Risk factors of BCa
typically include prolonged exposure to cigarette smokes, chemicals in work-
places (such as in dye, rubber, textile, leather factories), exposure to arsenic,
previous BCa diagnosis, genetic predisposition, age, gender and low fluid in-
take. Smoking tobacco is the most common risk factors of BCa and it accounts
6Lymphomas, Leukaemias and Sarcomas are some of the other types of cancers which
occur in the lymph nodes, bloodstream and fat/bone/muscles respectively.
7Epithelium is one of four tissue types in animals. Epithelial cells line the surfaces of all
organs in humans. Cancers arising from organs such as bladder, lungs, colon, prostate and
breast are typically carcinomas
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Figure 2.2: The Bladder consists of four main layers [11]. Bladder cancer
typically starts from the innermost layer (the urothelium). According to the
TNM classification [11], non-muscle invasive tumours consist of T1, Ta and
Tis. The stages of BCa in increasing order of advancement/aggressiveness
are: CIS, Ta, T1 T2, T2a, T2b, T3, T3a, T3b, T4, T4a, T4b.
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for about 50% of BCas. The study in [13] shows that fruit and vegetable in-
take lowers the risk of BCa but the link between dietary and BCa generally
remains controversial [1].
As can be seen in Fig. 2.2, as BCa moves from the urothelium into other
layers, it becomes more progressive and more dangerous. BCas are often
described by how far they have progressed into neighbouring layers of the
bladder. Non-Invasive is where the cancer cells are still within the urothe-
lium and have not grown deeper. Superficial/non-muscle invasive means the
diagnosed BCa is non-invasive and has not progressed to the muscles of the
bladder. Invasive means the cancer cells have grown into the lamina propria
or perhaps even deeper into the outer muscle layer. Metastatic is the most
advanced and refers to when the cancerous cells have spread through lymph
nodes to attack other organs and tissues of the body.
2.2.1.1 Testing for Bladder Cancer
Diagnosing BCa is symptomatic and based on history and clinical investigation
of the patient. The most common presenting symptoms are painless and in-
termittent visible (sometimes invisible) haematuria (blood in the urine) and
recurring urinary tract infections (UTIs). However, haematuria and voiding
symptoms may be present with other bladder diseases, therefore differential
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diagnosis such as prostate cancer and urinary tract calculi are usually consid-
ered. When BCa is suspected, the oncology provider typically performs uri-
nalysis, abdominal investigation, digital rectal examination and cystoscopy.
Cystocopy involves inserting a cystocope (a small flexible lens tube) into the
bladder through the urethra. If a tumour is suspected present in the area, the
tumour is removed and cell samples sent off to be ’biopsied’. Biopsy means
looking into these sample tumour cells under a microscope. With advances
in technology, imaging tests such as the computerized tomography urogram,
are increasingly being used. These advanced forms of diagnosis can locate the
site, the size of tumour and any evidence of metastasis or hydronephrosis. It
is also normal to test other organs of the body to see if the BCa has metas-
tasised. During a biopsy, the pathologist typically searches for poorly defined
cell boundaries, disorganised arrangements, irregularly shaped nuclei/ cells
as well as variations in cell shape and size. This would inform the pathologist
on the grade, the stage,the type of cancer, its invasiveness and if metastasis
has occurred.
2.2.1.2 Management and Treatment Options for Bladder Cancer
Treatment decisions are usually made by taking into account several factors
which include patient and disease characteristics. The grade of BCa tells how
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much different the cancer cells/tissues are to normal cells/tissues. High grade
tumours tend to grow faster than low grade tumours. The BCa stage refers to
how deep the cancer cells have progressed from the urothelium or whether
they have spread to other organs of the body. The TNM staging is the staging
model of choice by most oncology providers. It tells the size of the tumour
(T), whether the cancerous cells have spread to nearby lymph nodes (N)
and if metastasis (M) is present. The T is usually found from the grade after
biopsy (Fig. 2.2) [12]. Some of the treatments [14] typically administered
include:
• Transurethral resection refers to the surgical removal of the tu-
mour and the surrounding tissue. This is a more common treat-
ment for the earlier stages of BCa.
• Cystectomy, which refers to total or partial removal of the blad-
der, sometimes along with the lymph nodes. This treatment is
typically administered in more advanced BCas and is the recom-
mended treatment for muscle-invasive tumours.
• Adjuvant intravesical Chemotherapy (mytomin C) is performed
mainly on patients with muscle-invasive BCa to prevent it metas-




• Radiotherapy uses high energy beams aimed at the cancer cells
with the intention of killing them. Often used when cystectomy
is not desired and the patients whose disease is still in infancy.
Sometimes also used after surgery to kill cancer cells that may
‘go’ undetected.
Sometimes, when BCa has been treated, it may reoccur usually with a
significantly worse prognosis. Then, the BCa is said to have relapsed.
2.3 Modelling Literature
The availability of electronic medical records and technological advances in
data capture has presented opportunities and challenges for understanding
BCa using artificial intelligence and machine learning. This offers numerous
potentials to:
• Identifying in advance the section of the population more suscep-
tible to BCa thus helping in early diagnosis [15].
• Identifying, after diagnosis, the patients at greater risk of death so




• Providing recommendations for personalised/precision medical in-
terventions [17, 18, 19].
The next subsections discuss the opportunities that these techniques present,
survey the literature on how they have been used and discuss the challenges
of eliciting models especially from a BCa database.
2.3.1 Machine Learning and Data Mining in Medicine and
Healthcare
The use of data mining and machine learning techniques has grown signifi-
cantly recently due to availability of very fast and relatively inexpensive com-
puting platforms. These techniques have helped to uncover hidden meanings
and in understanding of large biomedical datasets. This has consequently
helped in uncovering new information and providing recommendations for
decisions as well as in generating new hypotheses from relatively large exper-
imental biomedical datasets. The following survey discusses the most widely
used machine learning techniques applied on the most important aspects of
medicine.
Broadly, machine learning and data mining techniques applied to medical
sciences may be classified as either descriptive (unsupervised) or predictive
(supervised) [20, 21, 22, 23]. The former is exploratory in nature and at-
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tempts to cluster the data so that observations are grouped according to how
similar they are. This leads to discovering previously unknown patterns and
relationships in the database thus helping in knowledge extraction. Descrip-
tive techniques include clustering, summarization, sequence discovery and
association [24]. The latter attempts to garner insights from labelled data so
that prediction is possible from the elicited models [24]. Predictive techniques
are further broadly classified into two: classification and regression. Classifi-
cation is for when the explanatory variable (output variable) is discrete and
the objective of the process is to elicit models capable of predicting which
group an arbitrary future observation belongs to (an observation can only be-
long to one of K groups). For example, consider the objective of finding if
a patient diagnosed with BCa is either of low or high risk of death from the
disease. The output variable being the risk of the patient could be one of two
groups; low or high. Regression, in contrast allows, for the possibility of the
output variable being a continuum. For example, consider the problem of pre-
dicting the time until a patient relapses from BC. Time being a continuous vari-
able makes the problem a regression problem [25]. Descriptive methods have
been widely used in the medical literature. Clustering, in particular, has been
the technique of choice in micro-array analysis because very little is known
about the gene data. Co-expressed genes are usually clustered/grouped such
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that they are co-regulated and in many cases share biological functions [26].
The co-expressed genes consequently help in identifying meaningful informa-
tion which was previously unknown [27]. One of the seminal applications of
understanding micro-array data using clustering is Van’t Veer’s analysis of 98
primary breast tumours using hierarchical clustering [28] where the goal was
to establish the likelihood of relapse. A thorough survey of the applications of
machine learning techniques in medicine is given in [29, 20].
Predictive techniques (classification and regression) are also widely used
in medical applications. Classification, for example, has been used in the di-
agnosis of diseases [30, 31, 32, 33, 34] and to predict outcomes of diseases
in medicine [35, 36, 37]. The artificial neural network (ANN) is arguably the
most popular predictive algorithm used in both classification and regression
(see Fig. 2.3). It has very powerful interpolation capabilities especially when
there is a large amount of data. However, many health professionals find un-
derstanding how the decisions are reached perplexing because of its relatively
opaque nature which has resulted in limited adoptions in practice. Another
popular classification algorithm is the decision tree because it is very intuitive
and fast. A decision tree algorithm, introduced by Ross Quinland in 1979, also
known as the Iterative Dichotomiser (ID3) [38, 20] and its variants including






















Figure 2.3: Artificial neural network block diagram.
[20] (Fig. 2.4). Decision trees are ideal candidates for data with small fea-
tures. However, when the data include very large number of features, then
decision trees may often result in overly complex models which are difficult to
understand. This makes them unsuitable for analysing the so called ‘big data’.







Excessive Normal No Yes
-VE -VE+VE +VE
+ve
Figure 2.4: Should I play football or not? The decision tree algorithm can
help answer this sort of question based on data and some selected attributes
(the weather in this case). See [38] for detailed discussions of the popular
ID3 decision tree algorithm. -ve = No, +ve = Yes.
erful classification algorithm. In the 1990’s, Vladimir, Vapnik and co-workers
at the AT&T Bell Laboratories introduced two powerful SVM algorithms which
use statistical learning theory to solve a binary classification problem by find-
ing the optimal hyperplane [40]. The first [41] allows for a linear kernel
function only while the second allows for more accurate classification perfor-
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mances by including polynomial and radial basis function (RBF) [42] kernels.
SVMs have been used to predict the muscle invasiveness of BCa [43] and in
many other medical applications [44] [45] and are particularly suited to im-
balance data.
Many cancer studies have attempted to compare various classification and
regression algorithms. For example, Hu and colleagues performed a com-
prehensive comparative study on different classification algorithms applied to
micro-array data analysis [46]. SVMs, decision trees and ensemble methods
were performed on seven publicly available micro-array data sets (Kent Ridge
biomedical dataset repository http://datam.i2r.a-star.edu.sg/datasets/krdb) with
SVM producing the best results on most data sets after 10 fold cross validation
for all the techniques. The Discriminant analysis (DA), logistic models, CART
and ANNs were also compared in the study by Harper in [47].
A comprehensive survey of regression modelling approaches in healthcare
is given by [48].
AI permeates all aspects of medicine as studied by [49] where analysis of
papers submitted to the international conference on Artificial Intelligence in
MEdicine (AIME) showed the application of AI techniques on a wide range
of research themes ranging from ontology and terminology, planning and
scheduling, uncertainty management in diverse medical fields.
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2.3.2 Artificial Intelligence in Cancer Studies
For many cancer studies, a wide range of AI techniques has been used to
infer how prognostic factors or input variables (such as age, tumour size,
lifestyle) influence the outcome of the disease. Definition of this outcome is
dependent on the study in question and could be subdivided into risk groups
[50, 51, 52, 53], prediction of time to death [54] or time to relapse [55, 56]
and status (alive or dead, relapsed) after a time period [57, 58, 59].
The next subsections review the most influential techniques for cancer
prognosis with particular attention on BCa. The techniques are broadly di-
vided into two categories: statistical techniques and computational intelli-
gence techniques which will be discussed in turn.
2.3.3 Explicit Statistical Techniques
In the 17th century, the prospects of applying probability theory was widely
debated amongst physicians who believed treatment interventions given to
patients require only professional judgement and should not be influenced
by quantitative analysis. The argument against the use of quantitative judge-
ments in medicine was that each patient was unique and it was impossible for




However, French Mathematician, Laplace (1749-1827) who had been work-
ing on probability theory and had published many books at that time dis-
agreed. Laplace believed that the correct treatment method would become
apparent with increasing observations [61, 62, 60]. Laplace argued that prob-
ability theory provides the foundation for understanding ALL uncertainties
and the peculiarities of patients can accurately be captured from the view-
point of probability theory [63, 64]. Physician Pierre-Charles-Alexandre Louis
(1787-1872) is perhaps the first recorded prominent use of probability the-
ory in medicine which was applied to the study of typhoid fever. In his study
from 1822-1827, patient data were recorded and used to determine how sur-
vival time of typhoid fever patients living in Paris differed from those living
outside of Paris. Louis’ conclusion that the subgroup who resided in Paris
lived longer triggered further debates in France and cultivated more inter-
ests in using statistical techniques to understand diseases. It was not until
the 1950’s, however, that the use of statistical science recorded tremendous
growth through the use of random trials (due to the father of modern statistics
Sir Ronald A. Fisher) for understanding disease outcomes. It was at this point
8Indeed, Francois Double (1776-1842) was famously quoted as saying Denis Poisson’s
(1781-1840) attempt at mathematicising medical decisions were useless and Lambert Adolphe
Jacques Quetelet (1796 -1874)’s use of the ‘average man’ akin to a "shoemaker who after hav-




that survival analysis began to gain prominence in cancer studies particularly
due to the influential surveys of Berkson and Gage [65] and Cutler and Ederer
[66]. It soon dawned on oncology researchers that survival analysis, a tech-
nique which had been the mainstay of 17th century actuary and demography,
could solve the particular troublesome problem of censoring9 as exemplified
by Berkson’s 1950 [65] study on the survival rates of cancer patients.
Models based on survival analysis can broadly be divided into non-parametric,
semi-parametric and Parametric as discussed next.
2.3.3.1 Non-parametric, Semi-Parametric and Parametric Models
Kaplan and Meier in [67] popularised the non-parametric approach to survival
data modelling. This technique now popularly known as the Kaplan-Meier es-
timator (KMe) is perhaps the most widely used survival analysis technique for
analysing a homogeneous population. It is usually called non-parametric be-
cause no assumption is made about the distribution of the data and the models
and analysis are based on non-parametric maximum likelihood method. The
Kaplan-Meier method has been used in several studies to determine BCa out-
comes. For example, [68] used it to determine muscle invasive BCa subtypes’
sensitivity to frontline chemotherapy. See [69] and [70] for other excellent
recent applications to BCa prognosis. The Kaplan-Meier method was one of
9This is discussed extensively in chapters 5 and 6
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the selected techniques used to analyse the BCa data in this research as dis-
cussed in Chapter 5. The use of parametric models became more pronounced
in the mid 20th century in medical cancer applications through the revolution-
ising works of Boag [71] where the study investigated how cancer therapies
influenced the five-year survival rate for different cancers using lognormally
distributed models. The advantage of the parametric methods is that covari-
ates can be seamlessly introduced to allow for a more robust analysis of a
heterogeneous population. However, one has to make the strong assumption
that survival times follow a particular distribution. Cox, not satisfied with
this limiting assumption, introduced a technique that is arguably the most
important in the medical cancer literature in [72] where the so-called semi-
parametric regression model is used on the hazard10. The Cox modelling
framework is discussed extensively in [73, 74]. The Cox model was particular
influential because assumptions are kept to the minimum and this has re-
sulted in many researchers adopting the technique particularly in BCa studies
[75, 76, 77, 78, 79].
2.3.3.2 Bayesian Methods
The KMe and Cox methods are based on the ‘frequentist approach’ where the
the goal of analysis is to find a set of parameters that best explains the data.
10The hazard is the instantaneous risk of death from a particular disease.
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The Bayesian approach takes the view that there is an uncertainty involved
in these parameter sets which should be quantified. Additionally, by using
the Bayes’ rule, subjectivity can be introduced in the form of a prior. The use
of Bayesian analysis in BCa models is rather limited perhaps due to the fact
that the complexities of the BCa database would inevitably lead to analytical
intractability of the resulting Bayesian models. Numerical methods like the
Markov Chain Monte Carlo [80] and Variational methods [81] could also be
prohibitively expensive. However, as discussed in [82], the Bayesian paradigm
offers the interesting and important capability to quantify and understand the
uncertainties in predictions. Additionally, in many cases, the frequentist ap-
proach is a special case of Bayesian view, with the Bayesian model offering
a more general approach to data analysis. In Chapter 4 of this thesis, the
Bayesian paradigm is combined in a new manner with interval type-2 fuzzy
modelling resulting in a model capable of handling and quantifying both lin-
guistic and random uncertainties embedded in the modelling process.
2.3.3.3 Other Statistical Approaches
Statistical methods in medical studies and especially in cancer studies con-
tinue to evolve. An active research area is the use of counting processes to sur-
vival data modelling introduced in Aalen’s PhD thesis in 1975. This approach
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remained unexplored for many years but enjoying attention in recent years in
the medical literature [83]. The approach allows for simplified analysis and
particularly extends well to multistate processes (the subject of Chapter 6 of
this thesis). The counting processes methods and general stochastic processes
methods are excellently discussed in books by Fleming in [84], Andersen et al
in [85] and in particular Aalen et al in [86].
2.3.4 Computational Intelligence Techniques
Computational intelligence (CI) refers to a set of a nature-inspired algorithms
developed to address very complex problems [87]. These algorithms, espe-
cially those based on fuzzy logic [88], artificial neural networks (ANN) [89]
and evolutionary computation [90], have been applied successfully to a wide
range of applications ranging from engineering [91], bio-medicine [92, 93]
and finance [94]. They have proved particularly successful in medical appli-
cations because of their ability to work with incomplete knowledge or uncer-
tainty. In urological oncology, for example, they have been successfully ap-
plied in optimising diagnosis [95], staging [96], determining novel biomark-
ers [55, 97, 98] and prognostic prediction [99] as well as performing data
mining on large micro-array data sets [100]. In BCa prognosis, CI (fuzzy
logic) has been used to predict BCa behaviour [101]. Catto et al in [55] com-
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pared ANN, Logistic regression (LR) and an Neuro-Fuzzy Modelling (NFM)
techniques in order to determine prognosis after a 5-year period. They found
that the two AI-based (ANN & NFM) methods outperformed the LR but noted
that the NFM method may be more beneficial since it provides a transparent
model. In their subsequent studies, using larger set of variables, they found
the NFM to be more accurate [101] than both ANN and LR11. In terms of
comparison expert prior knowledge with AI techniques, Qureshi et al in [91]
found ANN to be more accurate for muscle invasive disease (62% vs 82%
mortality accuracy) but was less accurate (72% vs 79% recurrence mortality)
in predicting superficial cancer behaviour. It would, however, be interesting
to compare the accuracies of these approaches with an hybridised version of
expert knowledge and ANN say in the framework of fuzzy modelling. CI tech-
niques have also been successfully applied to urological imaging and treat-
ment planning. For example, Feleppa et al in [102] developed an automated
image analysis which is similar to those for diagnosis and radiotherapy plan-
ning in histopathology which bypasses the dependence of error-prone human
operators. Maclin in [103] with 99% accuracy trained an ANN to accurately
recognise renal ultrasound images. The NFM approach has also been used
in automated tumour diagnosis using spectral imaging parameters [104] with
11Although, NFM is a special case of ANN.
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more than 10% improvement in accuracy over the conventional method (near-
est neighbour classifier).
In medicine as a whole, fuzzy systems have found important applications
in many areas ranging from neurology, pediatry and pharmacology. Abbod et
al in [105] have surveyed comprehensively the utilisation of fuzzy systems in
medicine and healthcare.
In summary, CI techniques continue to be pivotal in helping to understand
cancer databases because of the strengths earlier discussed. Algorithms based
on fuzzy logic, in particular, relate well with these databases and medical ap-
plications because of extensive expert knowledge for which fuzzy sets allow
for easy integration. The type-2 approach to fuzzy modelling can help handle
linguistic uncertainties (see Chapter 3). However, in the presence of random
noise (as is typical in BCa modelling), existing fuzzy technologies may not
adequately handle these uncertainties which may result in wrong inference
leading to catastrophic effects on the patients lives. It is argued in this the-
sis, that a synergistic combination of statistical approaches with fuzzy models
would lead to significant lead to more robust and accurate models. There
exist some approaches at this as discussed in the following section.
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2.3.4.1 Hybrid Models
The use of techniques that attempt to hybridise statistical methods with com-
putational intelligence methods is plentiful in the literature.
Some of these techniques include local fitting methods [106, 107, 108],
where the linear model βTx is replaced by a locally linear function. The use of
splines in conjunction with the Cox model is also ubiquitous which allows for
more flexible modelling of parameter β such as the work in [109] which mod-
els hazard functions directly without the use of smoothing splines as opposed
to Gu’s use of smoothing splines [110]. Additive models have also been used
widely where the linear parts of statistical models are replaced by a summa-
tion of functions
∑
i fi(xi) in a similar fashion as a fuzzy model under simple
assumptions and are described in detail in [111, 112, 113, 114, 115]. Extend-
ing adaptive models, [116, 117, 118] allowed fi to be a function of time in a
manner similar to time dependent variables of the Cox model [119].
2.4 Adequacy of Existing Techniques - Uncertainties
and Challenges
Unlike physical systems, the complexities of medical systems make the devel-
opment of intelligent decision systems not so straightforward. This is even
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more so in eliciting intelligent decision support systems for BCa database
because of inherent uncertainties, high dimensionality, complex variable in-
teractions, missing data, censored observations. This can effectively render
traditional quantitative techniques grossly inadequate and inappropriate. For
example, the widely and usually robust logistic regression would fail when
applied to survival modelling of BCa [120]. Similarly, traditional fuzzy mod-
elling approaches though having been shown to be able to represent incom-
plete and approximate human knowledge seamlessly will lead to biased mod-
els if censored12 variables are not adequately accounted for. For example,
in a typical BCa database, it has been shown in [7] that the risk of a pa-
tient changes with time due to the new information obtained during patient
follow-ups examinations. For example, initial risk estimates become invalid
for a patient who has been found to have relapsed from BCa after undergoing
the initial treatment i.e. intermediate events alter likely future behaviour the
disease. Therefore, medical data typically contain time-series attributes which
would bias elicited models if they were not adequately handled. Medical data
are usually gathered during the course of caring for a patient. And this makes
the medical data less reliable and of inferior quality compared with those
from other fields. The reason for this is because patients treatments are di-
12This is explained in Chapter 5.
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verse and patients have unique lifestyles which are not usually recorded in the
databases. Additionally, in many medical data gathering process, the culture
of patients and clinicians filling details of sicknesses, diseases and patient his-
tories is still prevalent. To facilitate data mining, these paper databases must
be transformed digital forms. This process presents challenges in gathering
highly reliable data as follows:
• Without adequate patient data gathering process, patients and
clinicians can easily not enter key details. For example, patient
filling personal history during follow can easily forget or even re-
luctant to provide significant events during follow-ups.
• Significant data preparation is often required, many data imputa-
tion stages are usually carried out by humans and it is not impos-
sible to find a particular person required to impute 100 of thou-
sands patient records into the computer. Human errors are fairly
common and this can corrupt the data.
• Privacy and legal issues are major concerns in the medical field.
Many of legal and ethical considerations must be taken into ac-
count. The need to protect the confidentiality of patients often
contrast the ability of clinicians and researchers to get highly re-
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liable and quality data. Also, there is still considerable debate
about the legal implications of actually implementing artificial
intelligence-based treatment recommendations [20]. This can cause
reluctance in implementing these models. This point further but-
tresses the need for elicited models to be transparent and open
to scrutiny which is the main reason for considering fuzzy logic
models in this research project.
The above consideration combined with the peculiarities of the BCa database
makes necessary developing new algorithms. As will be seen in subsequent
chapters of this thesis, the BCa database involved patient histories of disease
information such as relapse. Because this information is dynamic in man-
ner (i.e. obtained during patients’ follow-ups at different time points), an
algorithm capable of incorporating this dynamic information to dynamically
update the predictions is, hence, needed; multistate approaches allow for this
seamless integration. However, because of computational infeasibility and
transparency problems, many of the approaches use simple linear models.
These linear models may not be tenable when covariates influence progno-
sis in a complex non-linear manner. Existing fuzzy modelling approaches
(though resulting in non-linear transparent models) and CI approaches un-
fortunately may fail to adequately handle and incorporate this important dy-
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namic information. This thesis proposes and projects to implement a new
modelling framework that synergistically combine fuzzy models and multi-
state approaches in analysis the BCa database via a dynamic risk map for new
patients diagnosed with BCa. The elicited models exploit the strengths of the
transparency and non-linear inference capabilities of fuzzy models combined
with the dynamic prediction capabilities of multistate models.
2.5 Summary
This chapter has provided an extensive literature survey on existing method-
ologies for cancer risk modelling with particular emphasis on bladder cancer
models. The challenges of eliciting such models which include problems re-
lating to censoring, high dimensionality and complex disease behaviour has
been discussed. The justification for selecting fuzzy modelling framework in a
bid to address these problems has also been discussed. The next chapter will
review the literature on existing fuzzy modelling frameworks with particular
emphasis on the type-2 fuzzy modelling configuration. A new method for the
systematic elicitation of fuzzy models from data will also be proposed.
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Chapter 3
Interval Type-2 Fuzzy Logic
Systems - An Approach for
Systematic Elicitation from
Data.
Our understanding of many complex systems is imprecise and sometimes de-
pendent on the individual. Such subjective knowledge lacks precise mathe-
matical basis (in contrast to objective knowledge). For example, consider the
effect of systemic chemotherapy on a distant metastasised BCa patient: as
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explained in chapter 2, the patient is considered high risk with bad progno-
sis. This therapy (systemic chemotherapy) is known, through experience, to
lower the risk and improve prognosis for this patient. However, it is difficult to
explain exactly in mathematical terms how this therapy affects the risk of the
patient. Only a linguistic explanation, based on expert knowledge is available.
The expert knowledge may, for example, be of the following form: adjuvant
intravesical chemotherapy tends to lower 5-year death risk on distant metastas-
tic BCa patients. It is such systems that fuzzy logic particularly lends itself to.
This is because Fuzzy logic, introduced by Zadeh in 1965 [121], allows one
to seamlessly represent such imprecise information in a principled manner as
discussed in succeeding subsections. Fuzzy logic extends conventional bivari-
ate logic by allowing partial truth. In relation to set theory, this means that an
element may belong to a set partially. This contrasts with classical sets where
an element can only either belong to the set or not all. The heart of fuzzy
logic systems (FLSs) is the fuzzy set (FS) which declares with certainty if and
to what degree an element belongs to that particular set . Debates about how
this degree of membership should be represented have resulted in two broad
categories of FLSs: the Type-1 FLS (T1 FLS) and Type-2 FLS (T2 FLS). These
categories of FLSs as well as the justification for adopting the interval T2 FLS
(IT2 FLS) approach in this research is discussed in this chapter. The chapter
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concludes by providing a comparative study of the proposed framework with
existing techniques of the same type.
3.1 Type-1 Fuzzy Logic Systems
The notion of set membership is pivotal to representing subjective knowledge
using fuzzy logic. The central object in fuzzy logic is this FS which describes
the subjective knowledge an individual has about the meaning of a word.
Mathematically a FS in the universe of discourse X is set of ordered pairs of
an element x ∈ X and its MF defined as follows:
A := {(x, µA(x))|x ∈ X} (3.1)
Consequently, X can viewed as the space of a linguistic variable u which may
take linguistic values such as moderately high. The elements x in X are some-
times used interchangeably to mean a linguistic variable. Typical linguistic
values for, say, the linguistic variable height may include low, medium high,
tall, short which are labels easily interpreted by us humans. Therefore, it can
be seen that a FS A generalises the crisp set by allowing elements of the set
A defined in the universe of discourse X to have a degree of membership
defined by the membership function (MF) µA(x). The MF is a measure that
shows the degree of similarity of an element in X to the FS A. The concept of
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a FS may also be represented diagrammatically as shown in Fig. 3.1.
To be able to incorporate fuzzy logic and FSs in engineering systems, FSs
are typically used to represent the variables of the system with inference car-
ried out using the so-called fuzzy inference engine (FIS). This arrangement
results in the fuzzy logic system (FLS) which is shown in Fig. 3.2.
The FLS provides a mapping from the input space X to the output space
Y so that the block diagram of Fig. 3.2 can be seen as y = f(x). The details
relating to all component of this block diagram are as follows:
• Fuzzification: This process makes the crisp input quantities fuzzy.
The premise behind fuzzification is that many quantities which
are presumed crisp actually carry a significant amount of uncer-
tainty. For example the quantity about 6 feet tall carry uncertainty
in terms of vagueness of information. The ammeter usually out-
puts crisp current values but this could be subject to several er-
rors which would result in imprecision. Fuzzification provides a
mechanism to represent and consequently handle these types of
uncertainties. Fuzzification is the mapping of a crisp value of the
ith input variable, i.e. xi = x∗i , into a fuzzy number (similar to
that of Fig. 3.1a). In many applications, singleton (as opposed
to non-singleton) fuzzification is the preferred choice since it is
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(a) Typical Fuzzy Set. The elements (x) of the universe of discourse
(X) have degree of membership in that particular FS. This degree of
















Height (ft)5ft 7ft5ft 7in
0.0
0.56
(b) Fuzzy Set representation of moderately tall. A person of height
5ft7inwould have a degree of membership of 0.56 in this moderately
tall FS.
Figure 3.1: Type-1 Fuzzy Sets
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Figure 3.2: A fuzzy Logic system
more mathematically tractable and results in a significant com-
putational cost saving. Singleton fuzzification is one where the
membership value is unity at x∗i and zero everywhere else which
contrast to nonsingleton fuzzification where the membership is
unity at x∗i but slowly decreases as one moves farther away from
x∗i (again in a manner to that obtained in Fig. 3.1a). Singleton
fuzzification is adopted in this research. Readers are referred to
[122] for detailed analyses of the different fuzzification types.
• Rule Base: The fuzzy rule base provides a linguistic mapping from
the input variables to the output variable. This is what makes
fuzzy systems relatable to humans since the rules are IF-THEN
rules. A sample rule is of the following form:
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Rl : IF x1 is Al1 and x2 is A
l
2 · · · and xn is Aln, THEN yl is Bl
(3.2)
where All and Bl are fuzzy sets (Fig. 3.1a), xi, ∀i = 1 : n repre-
sents the ith input domain and y is the output. IFM is the number
of fuzzy rules, then l = 1, 2, . . . ,M . The IF part is called the an-
tecedent and the THEN part is referred to as the consequent.
• Inference Engine: The inference engine or the fuzzy inference
engine (FIS) is the heart of the FLS and it is where fuzzy logic
principles are incorporated into the fuzzy IF-THEN rules and the
FSs (both input and output). For a FLS with M rules with R(l) be-
ing the lth rule for l = 1, 2, · · · ,M and n inputs x1, . . . , xn (hence-
forth represented by the vector x), the steps involved in the FIS
mechanism is as follows:
1. For each fuzzy IF - THEN rule, determine the MF µAl1?···?Aln(x)
for l = 1, 2, . . . ,M where ? is the t-norm operator
which is usually selected to be the minimum or prod-
uct. The product formulation for the t-norm operator
is used in this project. The t-norm operator represents
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how the AND part of the fuzzy IF-THEN rules are com-
bined.
2. Calculate µBl(x, y) = µAl1?···?Aln→Bl(x, y). This is the
THEN part of the fuzzy rule and is called IMPLICA-
TION. As is the case for calculating the AND part for
multiple inputs, the implication is calculated by using
the t-norm which is typically a product or a minimum.
Again, the product t-norm is used in this project. At
this point, one is left with M FSs (i.e. µBl(x, y) for
l = 1, 2, . . . ,M .
3. Combine the M FSs using the s-norm operator which
results in a composite FS i.e.
B = ∪Ml=1Bl = µ′B(y) = µ1B(y), · · · ,µMB (y) (3.3)
where is the snorm or t-conorm operator commonly
implemented using max of probor [123, 124].
• Defuzzification: For many engineering systems, the output is
usually crisp. Defuzzification produces this crisp output. Many
types of defuzzification techniques exist in the literature such as
the mean of maxima, centroid, center of sums and modified height
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[122, 124]. The centroid defuzzification method is adopted since
it is easily differentiable FLSs and results in smooth surfaces [125].






where the MF for the composite output MF calculated in step 2
above has been discretised into N points. It is worth noting that
yc is a function of the inputs (x).
3.1.1 Challenges with Using the Conventional Fuzzy Logic
System
Using the type of MFs shown in Fig. 3.1a for complex and highly uncertain
systems may not be tenable. This is because, as extensively discussed in [122]
and [126], this representation suffers from the severe limitation of oversim-
plifying real life scenarios. For example, it is entirely possible for two persons
to have different meaning and indeed different representation for the word
‘tall’ in Fig. 3.1a, such that there are different degrees of membership for all
or some of the elements of the FS in the universe of discourse. Fig. 3.3a
illustrates this point. This type of uncertainty is referred to as inter-person
uncertainty [122]. It is also possible for a person’s meaning about a word
to be ambiguous such that the crisp value of MF values in conventional FS
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(a) Two persons asked to provide an MF for the word ‘tall’ could











































































(b) Intrapersonal Uncertainty: An individuals MF might be ambigu-
ous which is akin to the blurring of these MFs or drawing the MFs
with a big marker. The degree of membership is no longer a crisp
value but an interval.
Figure 3.3: Uncertainties about a word.
is no longer tenable. This is usually referred to as intra-person uncertainty
because it represents the doubts that a person has about the meaning and
representation of a word and the idea is illustrated in Fig. 3.3b.
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(b) A T2 FS allows for capturing this uncertainty about the word tall
by means of the so-called footprint of uncertainty (FOU). The FOU
is the region covering the primary MF. More region covered means
more uncertainty about the word.
Figure 3.4: A Type-2 Fuzzy Set allows for capturing the uncertainties.
Earlier approaches to solving this problem include averaging [122] of the
MF values at specific points ( See Fig. 3.4a).
However, this can lead to considerable loss of information and degradation
of performance in systems with high uncertainties since variations in MF val-
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ues are not accounted for. To remedy this problem, Zadeh introduced a new
type of FS in 1975 [88] called the type-2 fuzzy set (T2 FS) (Fig. 3.4b). This
FS has a third dimension which allows for representing and handling such
linguistic uncertainties. The use of T2 FS in applications became increasingly
popular because of advances in computational power and extensive develop-
ments of its theories in the late 1990s and early 2000s [127, 128, 129, 130]. In
line with the literature, the conventional FSs are hitherto called type-1 fuzzy
sets (T1 FSs) with a FLS incorporating the T1 FS in all their MFs called Type-
1 fuzzy logic systems (T1 FLS). Type-2 fuzzy logic systems (T2 FLS) refer to
those FLSs which use at least one T2 FS in their MFs [129] and are discussed
further in the following sections.
3.2 Type-2 Fuzzy Logic Systems
Mathematically, a T2 FS, Ã, is given as follows:
Ã := {(x, u), µÃ(x, u)|∀x ∈ X,∀u ∈ Jx ⊆ [0, 1]} (3.5)
where X is the primary domain of the MF of A and Jx is the secondary do-
main. u is sometimes called the primary MF while µÃ(x, u) is called the sec-
ondary MF, 0 6 µÃ(x, u) 6 1. At each value of x = x
′, a 2D plane, which is
T1 FS is called the vertical slice (Fig. 3.4b). The wavy slice or embedded T1
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FS of Ã is a T1 FS that results when only one value of u for all elements x in
the universe of discourse. This representation is similar to that drawn for the
average MF in Fig. 3.4a.
Other representations of T2 FSs such as the z-slice/α-slice exist. Readers
are referred to [131] for a detailed analysis of the different representations of
the T2 FS.
There are two major differences between the T1 FLS and the T2 FLS (Fig.
3.5b). The first, as already mentioned, is the incorporation of the T2 FSs
as the MF of the FLS. The second is the presence of of type reduction (TR)
stage which reduces the T2 FSs at the output side of the FLS into a T1 FS
for subsequent defuzzification1. The TR stage can be computationally taxing
because it involves enumerating all embedded T1 FSs and then computing
the α tuples and computing the centroid of the centroid accordingly. α can
be very large depending on the level of discretization2, see [128] for details.
This computational cost has caused a reluctance in the ‘fuzzy community’ to
using the T2 FLS in practice3. Thankfully, there exist an efficient, precise and
1The TR stage is a consequence of the Extension Principle [88] and is an extension of the
type-1 defuzzification
2if the primary domain is discretized into N points and the secondary domain discretized
into Mj points for j = 1, 2, · · ·N , then α =
∏N
j=1Mj . Hence, for a modest level of discretiza-
tion, say Mj =M = 10 and N = 10, then α =
∏10
j=1 10 = 10
10 = 10 billion.
3Although, attempts at reducing this computational cost is burgeoning and showing good
promise, many of the developed algorithms return only approximate results. See [122] for an
informative survey of T2 FLSs in practice.
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Figure 3.5: T2 FS and T2 FLS.
accurate algorithm for a special type of T2 FSs called the interval type-2 fuzzy
set (IT2 FS) which is discussed in the following section.
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Figure 3.6: Fuzzy Sets
3.3 Interval Type-2 Fuzzy Sets
As already mentioned, the computational complexities of the T2 FLS may be
significantly reduced by following the so-called IT2 approach [132]. In IT2
FSs, the secondary MF is a type-1 interval as shown in Fig. 3.6 so that the
secondary membership grades are all unity.
This is expressed mathematically as follows:
Ã := {(x, u), µÃ(x, u) = 1|∀x ∈ X,∀u ∈ Jx ⊆ [0, 1]} (3.6)
It is worth noting at this point that in an IT2 FS, µÃ(x, u) = 1 ∀(x, u) while
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for the general T2 FS, 0 6 µÃ(x, u) 6 1 ∀(x, u). The Karnik-Mendel (KM)
algorithm allows for accurate and efficient type-reduction of the IT2 FS. Con-
sequently, one can see that using the IT2 FSs, there is a trade-off between
uncertainty handling/representation and high computational costs. It is for
this reason that this IT2 approach is considered in this thesis. To be able to
deploy such FSs in applications, the FSs must be represented in a parametric
form as shown in Fig. 3.7.
All other parts of the T2 FLS remain unchanged in the IT2 FLS and infer-
ence proceeds exactly as described in Sections 3.1 and 3.2.
3.4 Fuzzy Logic Systems Modelling
In the absence of or limited expert knowledge, FLSs are usually designed us-
ing input-output data in a manner similar to how the artificial neural network
is designed. The resulting fuzzy model then provides a linguistic representa-
tion of the data and the system in question. Automatic model elicitation from
data of T1 FLS and has been well studied in the literature, see [133, 134] for
a thorough review. The clustering method is the preferred method of choice
because it provides a rapid, transparent and accurate prototyping mechanism
[125]. Often, the model elicited from clustering is tuned further to produce
a more accurate model. In the case of designing the T2 FLS, it is imperative
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(c) Triangular MF. a, b, c, d and e com-
pletely define this MF.
Figure 3.7: Examples of Interval T2 FSs.
that the optimisation algorithm does not incur high computational costs since
the T2 FLS is already a costly arrangement. It is for this reason that the gra-
dient descent algorithm has been the method of choice in tuning the T2 FLS
from data. The gradient descent algorithm is, however, a local optima algo-
rithm and the common method of random initialisation of parameters [135]
may result in the algorithm repeatedly trapped in a local minimum. This sec-
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tion presents a more systematic method for selecting these initial parameters.
The section also provides a gradient descent algorithm for a new kind of IT2
FLS which allows for a new and relatively more efficient form of computa-
tion. The first step is to determine the structure of the system by clustering
the data following a similar approach used in [136]. However, here, a source
of uncertainty involving the fuzzifier, which regulates the degree of overlap
amongst the clusters when fuzzy c-means (FCM) clustering technique, is used
to elicit the initial structure of fuzzy models is taken into consideration. To
achieve this, a similar procedure introduced in [137] is followed which in-
volves making use of the interval type-2 fuzzy clustering algorithm developed
[138] to elicit the initial structure of the antecedent structure of the IT2 FLS.
This is a detour from the popular method of randomly initialising the width
of the IT2 FSs after having used FCM for the initial structure determination
with the fuzzifier value set to a constant value (usually set to 2) [135]. It is
argued in this research that this systematic approach of finding these initial
parameters has the potential to helping one build a more optimal fuzzy sys-
tem especially when no further parameter tuning is performed. Even when
the initial system is further optimised, local optima methods may return so-
lutions that are equal or not far off from global optimum solutions [139] i.e.
by making use of IT2 fuzzy clustering, good clustering results are returned
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and invariably good modelling performances. The research focusses on the
Takagi-Sugeno-Kang (TSK) T2 FLSs because these are are more general than
the Mamdani FLSs. The presented approach follows that obtainable in the
method proposed in [136, 140] which involves first finding the structure of
model using FCM clustering and further optimising these parameters. They
applied this technique to a T1 FLS while ours is implemented on an IT2 FLS.
The modelling paradigm involves first selecting the initial antecedent struc-
ture using IT2 fuzzy clustering and then the least-squares approach is used
to derive initial consequent parameters by making use of the Nie-Tan (NT)
defuzzification method [141]. This approach bypasses the computationally
demanding KM algorithm. Finally, the whole system is optimised using the
gradient descent optimisation algorithm. In building this framework, some
necessary assumptions have been made and this will be made clearer by some
sets of equations in the succeeding subsections.
3.4.1 Methodology
As seen in Fig. 3.8, the proposed methodology has three stages which consists
of initial structure determination by using a fuzzy clustering approach to de-
termine the antecedent parameters, followed by the use of a the least-squares
algorithm to determine the consequent parameters and finally optimising all
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Least-Squares for Initial
Consequent Parameters Estimation 
Optimisation of All Parameters 
Using Steepest Descent 
IT2 Fuzzy Clustering For Initial 
Antecedent Parameters Estimation
Figure 3.8: The various stages involved in the IT2 FLS Modelling framework.
the parameters of the FLS using a gradient descent approach. Each of the
stages is discussed further in the following subsections.



















where hi is the consequent value of the ith rule which is defined as hi =
βi0 + βi1x1 + βi2x2 + · · ·βinxn = βᵀx. βip are the consequent parameters for
p = 0, 1, 2, · · ·n and i = 1, · · · , c. For the Gaussian primary MF of fixed mean
and uncertain spread such as that shown in Fig. 3.7b, and using the product
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µij and µij are the upper and lower firing strengths respectively for the jth
antecedent MF of the ith rule for j = 1, 2, · · · , n and i = 1, 2, · · · , c.





where r is a c×1 vector of 1’s and F is a c×1 vector. It is worth noting that the
MFs are only associated with the antecedents since there are no consequent
MFs for a TSK FLS.
3.4.2 Clustering Methodology
As mentioned earlier, in this stage of the modelling process, the initial struc-
ture and parameters of the antecedent MFs are obtained through the use of
the IT2 FCM algorithm. The parameters of these antecedent MFs are found
by projecting the UMF and LMF found from the fuzzy clusters to each input
subspaces. This approach follows directly from that obtainable in [140] which
uses this approach to find the antecedent initial parameters of a T1 FLS. The
centres and widths (consequently the variances) are derived from the fuzzy
means and fuzzy variances respectively of each input dimension after clus-
tering. For detailed discussions of how these antecedent parameters may be
found from the input subspaces projections, the reader is referred to [140]
and [136]. The flowchart for the clustering algorithm, is shown in Fig. 3.9.
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This is based on the interval type-2 fuzzy c-means (IT2 FCM) algorithm devel-
oped by Hwang in [138].
Fig. 3.10 shows a synthetic data set including two dimensions and the pro-
jections in each dimension for a fixed mean and uncertain standard deviation
IT2 FS after using the IT2 FCM to cluster the data (2 clusters, 2 fuzzy rules).
3.4.3 Least-Squares for Consequent Determination
The least-squares algorithm is used to determine the initial values for the
consequent part of the FLS. Recall from equation 3.7 the output of an IT2 FLS
using the Nie-Tan defuzzification method, the consequent parameters are the
βs. Now let




for p = 0, 1, · · · , n, where n is the number of input variables. Then the output
of a IT2 FLS can be re-expressed as follows:
fs = Bᵀψ (3.11)
where ψ is a vector of ψip for i = 1, . . . , c, p = 0, 1, . . . , n and B is a vector
of associated parameters. Least-squares parameter estimation leads to
B̂ = (ΨᵀΨ)−1ΨᵀY (3.12)
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No; vold = vnew
Yes
Figure 3.9: Flow Chart of the clustering algorithm.
65
3.4. Fuzzy Logic Systems Modelling
Figure 3.10: Synthetic data projection example.
where Y is a column vector of measured output data and Ψ is the design
matrix.
3.4.4 Optimisation
In [142], the derivatives for an IT2 FLS when making use of the KM algorithm
to type-reduce the FLS were derived. In this paper, following similar proce-
dures, the steepest descent algorithm is derived for an IT2 FLS but this time
using the NT method of defuzzification. The NT method bypasses the compu-
tationally demanding type-reduction stage when using the KM algorithm.
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For the particular antecedent or consequent parameter τ , the update gra-
dient descent algorithm tries to move ‘downhill’ as given by the following
equation:








where t is the iteration count and yi is the ith output for i = 1, . . . , N . The
challenge is to find the derivatives of ei with respect to all of the parameters
of IT2 FLS.
3.4.4.1 Antecedent Parameters
For the antecedent parameters (Gaussian primary MF of fixed mean and un-
certain spread), the derivatives are as follows:
∂e
∂θlij


















where θlij is the l
th parameter of the jth antecedent of the ith rule. For j =
1, 2, . . . , n, i = 1, 2, . . . , c and l ∈ v, σ, σ̄.
3.4.5 Consequent Parameters
The derivative of the consequent parameters is given as follows:
∂e
∂βip
= (fs − y)
(





3.5. Case-Study Steel prediction
where βip is the pth consequent parameter of the ith fuzzy rule, for p =
0, 1, 2, . . . , n and i = 1, 2, . . . , c.
3.5 Case-Study Steel prediction
This section presents the application of the proposed modelling framework
on real life engineering modelling problem involving the mechanical property
prediction of hot rolled steels. The performance index chosen in this prelim-







where N is the number of testing data,yk and ŷk are the kth actual output
and corresponding model output respectively. As will be discussed in Section
5, this performance index is not suitable for the BCa data because of presence
of the censored observations4. The goal of testing the proposed framework
on the selected problem is so as to compare it with existing models of the
same type on a highly complex prediction problem. The proposed modelling
framework is further tuned so as to be suitable for the BCa problem. The heat
treatment of hot-rolled steel is a complex and highly non-linear process. Data-
based models have been developed in the past to aid metallurgists design steel
4Explained extensively in chapter 5.
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alloys [135]. One of the goals of these models is to predict the ultimate tensile
strength (UTS) which is a common measure of metal strength. A total of 3760
data samples collected from the industry are used to elicit the models in this
research work. These data samples include 15 inputs and one output (which is
the UTS). 12 new data points were used for validating the final model. These
two data sets are independent (time-wise) but are from the same production
cycle and manufacture setting. Consequently, they have identical types and
number of input and output variables. 15 input variables and 1 output variable
( ultimate tensile strength (UTS) of the steel alloys in megapascal (MPa)) were
included in the study and are listed in Table 3.1. The distributions of some of
the inputs of the data are shown in Fig. 3.11.
Six fuzzy rules (corresponding to six clusters) were found from data us-
ing the elicited framework. Prediction performance of the elicited model is
shown in Fig. 3.12. The results are also compared with those available in the
literature [143, 144] which are shown in Table 3.2.
3.5.1 Analysis of Results
Table 3.2 shows the result of the proposed modelling framework compared
to elicited models of the same type in the literature. The proposed modelling
framework outperforms the other two models in both training and testing
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(a) Distribution of Test Depth (mm)
and UTS (MPa).
(b) Distribution of Hardening Temper-
ature (oC) against UTS (MPa).
(c) Distribution of amount of Silicon
(%) against UTS (MPa).
(d) Distribution of amount of Nickel
(%) against UTS (MPa).
Figure 3.11: Distribution of some of the input variables against the output
variable (UTS).
data as well as generalising well to the previously unseen 12 data points. The
six (6) rules for each input variable are shown in Fig 3.13.
3.6 Summary
This chapter has reviewed the literature on existing methods for fuzzy mod-
elling. The chapter has discussed the uncertainty handling advantages of the
type-2 configuration over the conventional type-1. A new systematic method
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Table 3.1: The input and output variables of the UTS dataset.
Input variable Output variable
1 Test Depth (mm) Ultimate Tensile
2 Size (mm) Strength (UTS)
3 Site Number in MegaPascal









13 Hardening Temperature (oC)
14 Cooling Medium
15 Temperature (oC)
Method Training Testing Validation
IT2-Squared 34.45 38.76 37.34
MOIT2FM 36.33 40.52 34.77
IMOFM_M 46.47 45.12 49.87
Table 3.2: Comparison of proposed method with those found in the Literature
for the prediction of UTS of steel (RMSE).
for eliciting interval type-2 fuzzy models from data has been discussed. This
method systematically initialises the parameters of the type-2 fuzzy model by
making use of the interval type-2 fuzzy clustering algorithm which is a shift
from existing method of random parameter initialisation. Compared with
models of a similar type, the proposed modelling framework shows signifi-
cant improvement in modelling performance. The next chapter will discuss
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(a) Training Data Results. (b) Testing Data Results.
(c) Indepent Data Results.
Figure 3.12: Results on the Prediction of UTS of steel.
the limitations of existing fuzzy modelling technologies and will propose new
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The previous chapter has introduced the different types of fuzzy logic systems
(FLSs) and how they can help to handle linguistic uncertainties. Using the
type-2 equivalent may lead to significant improvements in robustness of ap-
plications. However, for modelling problems such as those subject to random
uncertainties, as is the case with medical systems, even the use of T2 FLS may
not suffice in building such a robust model. The main problem with conven-
tional FLSs (both T1s and T2s) lies in the fact they must be represented with
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‘CERTAIN’ parameters. For example, in an IT2 FS with fixed mean and uncer-
tain width, such as shown in Fig. 3.7a in chapter 3, only one set of parameters
is selected after the optimisation stage. As such the ability of conventional
FLSs to handle random uncertainties is rather limited. However, one often
wishes to elicit these T2 FLSs from noisy data. For example, it can often be the
case that the same input values give rise to completely different outputs even
under constant experimental conditions. As discussed in [145], it is not un-
usual to find two patients diagnosed with the same cancer and having exactly
the same recorded covariates values but having widely varying risk or time
of death. Many factors may have accounted for this phenomenon including
measurement error , unobserved/unrecorded covariates and precision errors
[146].
Probabilistic formalisms, especially those based on the Bayesian paradigm,
provide a principled mechanism for handling such challenges. The follow-
ing sections discuss a new framework for integrating the Bayesian framework
with the fuzzy modelling paradigm. This proposed synergy maintains the
transparency that fuzzy logic provides in systems design whilst allowing for
understanding the uncertainties discussed from the viewpoint of the Bayesian
paradigm. The proposed framework is tested on an synthetic and an exper-





Quantifying uncertainties due to measurement errors are well understood and
established using the mature fields of probability theory and statistics. How-
ever, a unified framework for identifying, quantifying and mitigating the ef-
fects of these uncertainties in large scale complex systems with errors in mod-
els with a view to making informed decisions on such systems remains an
active research area. [146] details 5 areas where the quantifying of uncer-
tainties are critical for understanding the underlying phenomena and making
informed predictions which are weather, climate, hydrology and geology, nu-
clear reactors and biological systems. For example, it is more informative,
intuitive, accurate and in-line with how weather phenomena are observed
to predict in percentage the likelihood of, say, ‘rain tomorrow’ since weather
systems are so complex that it is impossible to know the certainty of rain.
Likewise, in biological systems such as in BCa studies, the system is equally
as complex, since there is incomplete understanding of the BCa process. It is
thus more natural, as in weather systems, to predict the likelihood of death
after the selected threshold of time say 5 years. The probabilistic formalism
can allow for such estimations as will be discussed shortly. However, it is im-
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perative to motivate and introduce a new representation of FSs proposed in
this thesis which is called the non-parametric fuzzy set NPFS before discussing
this new framework which is discussed in the next section.
4.3 Non-parametric Fuzzy Sets
The new representation of an FS is introduced via an example. Considering
an hypothetical scenario using the following two rules:
Rule 1: if the house is small then the price is low
Rule 2: if the house is big then the price is high
The uncertainty embedded in this rule is in defining the MF of the linguistic
variables small, big, low and high [127]. Suppose three persons are polled to
define the MFs for these rules. Different types (shapes and sizes) of MFs will
most likely result, as discussed in chapter 3. Now, suppose, for simplicity
of analysis, that three persons agree on the exactly the same MFs for small,
big, low but disagree on the MF for high. Fig. 4.1 shows hypothetical MFs
illustrating this point. A T2 FS can help one handle this difference in opinion
of the MF for high (see chapter 3). One way of obtaining a T2 FS is to merge
the MFs as shown in Fig. 4.2 [127], which will transform the existing T1 FLS
into a T2 FLS or a IT2 FLS.
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(a) Input domain.
(b) Output domain.
Figure 4.1: MFs for the Rules
The resulting output may be found according to the extension principle
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(a) Input domain.
(b) Output domain.
Figure 4.2: Merging of MFs results in a T2 FLS.
where M is the level of discretisation of the output domain, f(xk) is the sec-
ondary grade of uk at xk and ? is the t-norm operator. Equation (4.1) simply
states that all embedded T2 FSs are first enumerated, then the defuzzified val-
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(a) Persons 1 and 2 have similar MF for high.
(b) Persons 2 and 3 have similar MF for high.
(c) Resulting T1 interval after type reduction of a IT2 FS.
Figure 4.3: There is no change in the LMF and UMF of (a) and (b). Conse-
quently, there is no change in the L and R switch points (c). Uncertainty not
well accounted for.
ues are found according to the rightmost side of equation (4.1) and the degree
of truth of this new defuzzified value calculated by using the t-norm operator
of the corresponding secondary grades.
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Hence, for example, if the resulting MF is an IT2 FS, the TR set at the
output processing stage is a T1 interval according to the Karnik-Mendel algo-
rithms (Fig. 4.3c). The T1 interval basically states that there is an uncertainty
in the output which is defined by the left (L) and right (R) end points as
shown in Fig. 4.3c. Now, since for each of the merged MFs shown in Figs.
4.4a and 4.4b, the values of UMF and LMF remain unchanged, then the L and
R switch points and consequently the defuzzified output remains unchanged
even when person 2’s MF changes. Consequently, the fact that persons’ 1 and
2 MFs are close is not accounted for as shown in Fig. 4.4. Person 2’s MF is
subsumed in the merged IT2 FS and if it is moved even closer to person 3,
there are no changes in the resulting T1 interval after TR. Evidently this does
not correctly indicate the type of uncertainty in the FLS. If one merges this
MFs into a T2 FS, then the secondary MFs must be defined. This process is
difficult and may result in the loss of interpretability of the fuzzy system.
A better approach may be to leave the MFs as they are with each MF of
a particular variable having a corresponding value of antecedent and conse-
quent parts, as shown in Figs. 4.4c and 4.4d. This requires defining a new
representation of FSs which is called the non-parametric fuzzy set (NPFS) in
this thesis.
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(a) Persons 1 and 2 have similar MF for high
(b) Persons 2 and 3 have similar MF for high
(c) Defuzzified values without merging for (a)
(d) Defuzzified values without merging for (b)
Figure 4.4: By not merging and leaving the MFs as they are, one is able to
clearly distinguish the uncertainty in each of the defuzzified values. Conse-
quently, uncertainty is well accounted for.
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Interestingly, this is equivalent to the Bayesian approach thus providing a
powerful mechanism for handling both random and linguistic uncertainties.
This approach is akin to having a type of an hierarchical T1 FLS, each corre-
sponding to a particular FLS of the different persons polled.
4.3.1 Mathematical Representation
The NPFS is introduced mathematically in this section. Consider the Dirac
delta function, δ(x), x ∈ R which is an element in the universe of discourse,
X. The Dirac delta function is defined by the following properties:
δ(x) =

δ(x) =∞ : x = 0




δ(x)dx = 1. (4.2)
Then, for any function f(x), the following equation is obtained:
∫
X
f(x)δ(a) = f(a) (4.3)
where X is the space of x. Based on the definitions above, it is easy to show







where λ is the area of the fuzzy set, x(i) is the ith point of x and N is the
number of points used to represent the fuzzy set. To make it more concrete,
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As a result of the definition of the Dirac delta function, then one can show







For the maximum defuzzification, the following equation is obtained:
x̂∗ = arg max
x(i);i=1,··· ,N
µ(x(i)) (4.7)
other types of defuzzification may be derived following same logic.
How to choose the x(i)’s is easy and various computer packages exist for
sampling from a one-dimensional function [147]. To show that this method
works, examples of representing different fuzzy sets using the NPFS is pre-
sented shortly. The sampling method employed is the acceptance sampling
method. Details of this algorithm is available in [147]. Figs. 4.5 and 4.6
show examples of using the NPFS to represent these MFs. 10000 samples were
taken using the acceptance sampling method and the histogram was found
to be able to visualize the form of these samples. The form of the histogram
shows that the NPFS is a viable and a accurate representation of FSs.
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(a) The centroid and histogram














Figure 4.5: Gaussian Membership Function
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Defuzzified = 4.2844 NPFS
Real Function
(a) Trapezoidal Membership Function.



















Defuzzified = 2.6646 NPFS
Real Function




















Defuzzified = −0.0025006 NPFS
Real Function
(c) Mixtures of Gaussian Membership
Function. The centroid of the original
function is 0. Centroid of the NPFS rep-
resentation is −0.0025006.
Figure 4.6: The NPFS used in representing different types of MFs.
It should be noted from the centroid and histogram that the samples are
representative of the FSs.
It also worth noting that this method is applicable to both T1 FS and T2
86
4.4. Bayesian and Fuzzy Integration
FS. To represent a T2 FS, the secondary MFs (which are T1 FSs) are simply
replaced with the samples as illustrated in the preceding equations.
4.4 Bayesian and Fuzzy Integration
It is argued that one of the advantages of fuzzy reasoning in modelling is its
ability to obtain linguistic models of data without explicitly stating the proba-
bility distribution. This statement is not totally true because in building fuzzy
models from data, a loss/error function must be defined in the optimisation
stage. As shown in [148] and [25], for many models Bayesian reasoning in
modelling leads to a generalization from which different loss functions can
be derived by defining the type of likelihood and prior i.e. the loss functions
can be obtained as a special case of Bayesian inference with different types of
priors [82]. It should noted that, by defining a particular error function, the
distribution of the data has been implicitly assumed.
In the probabilistic paradigm, given a set of data D, D = {(xi, yi)|i =
1, · · · , N}, where x ∈ Rd is a vector of the input and y ∈ R is the output. The
goal of learning from data is to find a function f such that every data point,
f(xi) ≈ yi for all i. What differentiates learning algorithms from one another
is the nature of the function, f . For a FLS, the nature of f is as shown in
Fig. 3.5b. In the statistical sense, the generative assumption is usually made,
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whereby the observed output is the corrupted version of the deterministic
output from f as given by the following equation:
yi = f(xi,w) + ε (4.8)
where w is the parameters of f . The simplifying assumption that the observed
data are independent and identically distributed (IID) Gaussian distribution
with zero mean and variance σ2 is usually made such that ε ∼ N (0, σ2), or
equivalently:
p(y|xi,w) = N (f(xi,w), σ2) (4.9)
The noise model assumption and the data give rise to the dataset likelihood,
















The Bayesian paradigm involves one defining a prior distribution p(w)
over the parameters which expresses of our initial belief on the parameters of
the model.
The prior in the presence of evidence (data) is updated to a posterior
distribution using Bayes’ rule as follows:
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P (w|D) is called the posterior distribution of w in light of evidence D.
When a test input x∗ is given, the output y∗ is the posterior predictive distri-
bution obtained by marginalising out w as follows:
P (y∗|D) =
∫
P (y∗|w)P (w|D)dw (4.12)
The formation of a predictive distribution by the integration of equation
(4.12) is the essence of the Bayesian inference [149] which provides a system-
atic confidence in the output depending on the degree of random uncertainty
embedded in the data.
Prior elicitation is equivalent to expert knowledge incorporation in fuzzy
inference and it is a pivotal issue for both Bayesian and fuzzy inferences.
However, this information may not be easy to summarise in the form of a
prior probability density function (PDF). Readers are referred to [149] for the
best ways of eliciting these ‘informative priors’.
Until the advent of very fast computing platforms, the integrals of equa-
tions (4.11) and (4.12) have been a source of considerable controversy. The
highly computational demanding Monte Carlo methods are usually employed
for sampling from posterior distribution. To understand the idea behind sam-
pling from P (w|D), it should be noted that equation (4.12) is the same as
finding the expectation, E of P (y∗|w) with respect to P (w|D). As a result of
the law of large numbers [147], by taking n IID samples from p(z), the integral
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such as
∫

















where h(z) is a function of variable z whose expectation one wishes to evalu-
ate with respect to p(z); this is equivalent to equation (4.12). Fig. 4.7 shows
the results of sampling from a multimodal function (p(x) ∝ 0.3 exp(−0.2x2) +
0.7 exp(0.2(x − 10)2)) using the Metropolis-Hastings algorithm for 5000 iter-
ations [147]. [147] and [150] offer excellent expositions on the different
methods of Monte Carlo sampling.
It should be noted that P (y∗|D) obtained from equation (4.12) is a func-
tion of y. More often than not, one is interested in making a single guess:
when point predictions are needed (as is usually the case), it can be shown
that the estimator fw to choose to represent a function of w can be chosen





Squared error loss function results in a posterior mean [152], while the
absolute loss function estimates the median of the posterior, that is L[fw,w] =
|fw −w| [151].
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Figure 4.7: Intended distribution with histogram of different sizes of the
Monte Carlo samples.
4.4.1 Bayesian Approach
As mentioned earlier, the parameters of the FLS are assumed to be random
variables and the Bayesian reasoning applied. For a FLS with a total of P
parameters, for simplicity of analysis, a Gaussian prior with zero mean of the






‖ w ‖) (4.15)
where α is the inverse variance and is usually called an hyper-parameter be-
cause it is a parameter of a distribution of other parameters. The normalisa-
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It should be noted that, choosing the best prior which represents our prior
expert knowledge is of crucial importance. The book by Murphy [148] pro-
vides an excellent resource for this.

















fFLS(xi,wFLS) is a T1 FLS with vector of parameter wFLS. These parame-
ters are the width and spread of, say, a Gaussian MF and the weights of the
consequent part of a Takagi-Sugeno-Kang (TSK) FLS, yi is the ith observed
output for input xi for i = 1 · · ·N , with N being the number of data points.





To elicit a prediction given a new input vector x∗, as discussed earlier, the
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where fFLS(x∗,wFLS) is the output of the FLS. The posterior p(wFLS|D)is usu-
ally sampled from using Markov chain Monte Carlo techniques because the
integrals in the equations above are intractable and numerical methods break-
down when the dimension of the parameters is greater than twenty. After
sampling, different weight sets can be said to correspond a particular FLS. By
obtaining samples from the posterior and then making predictions using the
sampled weights, what basically results is a set of outputs which corresponds
to the non-parametric representation earlier discussed in this chapter (see
section 4.3). Every fuzzy set in the antecedent has as many embedded fuzzy
sets as there are number of weights. The only difference between the pro-
posed method and the conventional T2 FLS is that the proposed method says
that for every weight sampled in particular antecedent parameter, there cor-
responds another weight in the antecedent and consequent parameters which




Samples of the parameters are taken according to the posterior distribu-
tion of the parameters. Each parameter set corresponds to the parameters of
the FLS. Then the final defuzzified output is calculated using equation (4.7),
which is the NPFS earlier proposed.
The above definition proves to us that the Bayesian-fuzzy system approach
yields a NPFS at the output whose form may be approximated via curve esti-
mation methods (kernel density) like those of Fig. 4.6.
4.5 Results
This section presents the results of the proposed modelling framework on
two datasets. For both, the TSK FLS was used and the initial FLS parameters
initialised via the use of the fuzzy c-means (FCM) clustering algorithm as ex-
plained in chapter 3. The first dataset is a synthetic data and four clusters
(corresponding to four rules) were generated. The second dataset is a real
dataset from the metal industry and eight clusters (corresponding to eight
rules) were generated. The centroid defuzzification method was used on the




This section presents the results of using the Bayesian–fuzzy technique in the
modelling of a synthetic dataset obtained from the following non-linear func-
tion:
y = x21 + x
2
2 (4.22)
The function includes two input variables (x1 and x2) and one output
variable (y).
The training dataset is generated between −4 ≤ (x1, x2) ≤ 4 with an
increment of 1 but some points are removed as shown in Fig. 4.8b. 10 testing
data points were generated randomly from the uniform distribution U such
that
−6 ≤ (x1, x2) ≤ 10 (4.23)
The testing dataset is labelled (1 − 10) in Fig. 4.8c. The uncertainty of
prediction in areas with sparse data such as data points 1 and 4 should be
higher than those with less-sparse data such as 5 and 7. 1000 posterior weights
of the FLS were sampled using the Harmiltonian Monte Carlo technique [153]
as explained in the preceding section. Fig. 4.9 shows the result on the testing
data with the confidence bands.















































(b) The plot of the function after the cut.






















(c) The plot of the scatter with labels.
Figure 4.8: Sythetic Dataset
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RMS Error =  28.3061
Figure 4.9: Prediction results and confidence on the synthetic dataset.
finding the difference in the minimum and maximum of the resulting type-
reduced NPFS as shown in Fig. 4.10.
The degree of confidence on the training dataset is expected to be high
(the confidence band is expected to be low) and this is exactly the case as
shown in Fig. 4.11.
It is worth noting that data points 1 and 4 have confidences that are low
compared to data points 5 and 7. The resulting fuzzy rules for the antecedent
part is shown in Fig. 4.12.
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(a) Data Point 1.
























(b) Data Point 2.
























(c) Data Point 3.
























(d) Data Point 4.
























(e) Data Point 5.
























(f) Data Point 6.
























(g) Data Point 7.
























(h) Data Point 8.
























(i) Data Point 9.
























(j) Data Point 10.
Figure 4.10: Results of the Prediction of Synthetic Dataset.
4.5.2 Ultimate Tensile Strength of Steel Model
The proposed modelling approach is further tested on the steel data used in
chapter 3 which is a real data drawn from the metal industry whereby the ul-
timate tensile strength (UTS) of steel alloys are predicted prior to production.
This data set has been analysed in chapter 3. As already mentioned, there
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RMS Error =  1.5828
(a) Training Dataset Results.












RMS Error =  1.5828
(b) Training dataset performance with prediction confi-
dence.
Figure 4.11: Training dataset performances on the synthetic dataset.
are two sets of datasets each variables as listed in Table 3.1. The decision
not to combine these two datasets was taken so as to be able to test how the
model would perform on a completely remote dataset. Additionally, a visual
inspection of this second dataset revealed that the 7th and 8th data points
have exactly the same values for the inputs but different values for the output
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Figure 4.12: Rules generated from the synthetic dataset modelling.
which may perhaps be due to the random uncertainties embedded in the data
such as measurement precision or insufficient number of input variables as
already discussed. It may even be due to errors in the data entry stage by
the operator. These are the types of random uncertainties embedded in data
modelling that existing fuzzy models may not handle adequately. It would be
interesting to find out how the proposed framework handles this uncertainty
though.
The distribution of some of the input variables against the output variable
is shown in Fig. 3.11. It can be observed that the data are highly dense in
some areas and highly sparse in others. The first dataset was divided into
training (70% of the data) and testing (30%) of the data. The testing dataset
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was used to test the generalization performance of the elicited model.
4.5.2.1 Results
The proposed modelling framework can help one overcome this by giving us
a visual representation of this uncertainty in the form of an NPFS after type
reduction. It is able to discriminate between the data points that have been
subject to these uncertainties as shown in Figs. 4.14b, 4.14a, 4.15h and 4.15i.
The elicited model was able to model the uncertainty in the predictions in
these data points.
The modelling performances on the training, testing and 12 independent
dataset are shown in Fig. 4.13. Compared with existing models of simi-
lar type, our proposed framework returned very good results. The model
strength, however, lies in its ability to quantify the uncertainty of each pre-
dicted output as shown in Figs. 4.14 and 4.15. For example data point 12 has
more uncertainty compared to data points 3 and 4. It should be noted that
the points close to the middle of the plot tends to have higher confidence than
points at the extreme (data points 12, 2 and 1). This is reasonable as when
one observes the dataset distribution (Fig. 3.11), it can be seen that the data
tend to be denser at the centre of the plot. The model is not as certain for
data points with less density than it is for data points with more density.
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(a) Training Data Results.
(b) Testing Data Results.





























(c) Indepent Data Results.
Figure 4.13: Results on the prediction of UTS of steel
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(a) Second Dataset Results highlighting data points 8 and 9



























RMS Error =  41.3094
(b) Prediction with confidence
Figure 4.14: Second data set results.
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(a) Data Point 1
























(b) Data Point 2
























(c) Data Point 3
























(d) Data Point 4
























(e) Data Point 5
























(f) Data Point 6
























(g) Data Point 7
























(h) Data Point 8
























(i) Data Point 9
























(j) Data Point 10
























(k) Data Point 11
























(l) Data Point 12
Figure 4.15: Results of the prediction of UTS of steel.
4.6 Summary
The limitations of the existing fuzzy modelling technologies have been dis-
cussed in this chapter. Specifically, the chapter has emphasized that the capa-
bility of conventional type-1 and type-2 fuzzy logic systems to handle random
uncertainties is limited by providing examples and representations. To better
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handle random uncertainties, the chapter has introduced a fuzzy-Bayesian in-
tegration method whereby the parameters of the fuzzy models are taken to
be random variables. The proposed method was tested on real and synthetic
datasets which provided evidence of its better random uncertainty handling.
The next chapter will present extensive analysis of the bladder cancer data
used in this research. It will also provide an interval type-2 fuzzy modelling
framework which allows one to predict, beforehand, the risk of death of a new
patient diagnosed with bladder cancer.
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Chapter 5
Static Risk Model using an
Integrated Fuzzy Survival
Analysis Approach
It has already been highlighted that one of the key challenges in eliciting a
predictive model for the BCa data is censoring. Survival analysis techniques
provide the key to handling censored data. The use of standard survival anal-
ysis techniques (such as the Kaplan-Meier estimator and the Cox proportional
hazards model) on the BCa data as well as their strengths and weaknesses are
discussed in this chapter. In the final sections, the fuzzy modelling framework
proposed in earlier chapters is integrated with these standard techniques so
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that it is able to handle the peculiarities of the BCa database. This proposed
synergistic framework is tested on BCa data as well as on an artificial data.
Testing on the artificial data is based on the premise that, unlike in the BCa
data, it is possible to generate the ‘would be’ event times had the subject not
been censored. The elicited model is a static risk map because it does not al-
low to incorporate patient dynamic information. However, the elicited model,
as will be seen, provides useful insights for clinicians and patients. Results of
this new modelling framework are then compared with standard techniques
from both the BCa and artificial data.
5.1 Bladder Cancer Data Analysis
5.1.1 The Data
As discussed in chapter 1, the BCa data were obtained from a study of BCa
patients at the Royal Hallamshire Hospital in Sheffield, United Kingdom1. In
order to understand the long term consequence of BCa patients, the hospital
created a database of BCa patients between 1 January, 1994 and 31 Decem-
ber, 2009 [5]. Patients diagnosed with the disease, but who are still alive
after the study period, are automatically censored. There were 3634 patients
with primary BCa but those with insufficient follow up (< 6 months) were ex-
1Sole provider of urological services in the city of Sheffield, UK
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cluded from such analysis. Additionally, patients with missing covariates were
excluded from the analysis leaving 2918 patients in the database. Thirteen
(13) explanatory variables (input variables) were recorded for each patient
which included details on disease pathology, patient specific characteristics
and treatment interventions (if any). The data were anonymised to maintain
the privacy of patients in the study. Details of each variable are shown in Table
5.1 and Fig. 5.1.
The response variable is time of death from BCa in months. The median
survival time is 35.26 months (30 days taken equal to 1 month). Of the 2918
patients 2305 were censored (78.99%) due to end of study, loss to follow up
or death due to other causes.
The distribution of times is shown in Fig. 5.2. There is a higher proportion
of censored observations at longer follow-up times than at lower follow-up
times. This is typical in survival analysis and is due to the study having a fixed
duration which means that patients with largest follow up times tend to be
censored.
It is worth mentioning at this stage that treatment decisions (cystectomy
and/or radiotherapy) were implicitly modelled by including them as part of
the input variables. This can provide information on how these treatments
affect the risk prognostics index and can help in providing clinicians recom-
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(a) Input 1 (Sex)
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(c) Input 3 (Grade)
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(d) Input 4 (Stage)
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(i) Input 9 (Vascular)
values























































(m) Input 13 (Radiother-
apy)
Figure 5.1: Distributions of the explanatory variables
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Table 5.1: Input variables in the BCa data.
Continuous Variables Median Mean Range
Age 72.7 years 71.6 years 21.3 - 101.0 years
Stage 4.03 4.02 0 - 9






























mendations for therapy as already discussed.
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Time (months)















Figure 5.2: Histogram of the times of events for both censored and uncensored
observations for the bladder cancer data set. Patients with higher follow-up
times tend to be the most censored as is typical in survival data studies. This is
is because the study was for a limited amount of time and patients with high
event times become automatically censored at the conclusion of the test.
5.2 Survival Analysis Introduction
Survival analysis relates to the analysis of time until an event occurs. Mathe-
matically, if T is a random variable which represents the time an event occurs,
survival analysis is concerned with identifying P(T > t) from data. In survival
studies, the quantities of interest are given as follows:
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where Pr(A) denotes the probability of event A, h(t), S(t), H(t) and F (t) are
the hazard function, survivor function, cumulative hazard function and cumu-
lative distribution function for the random variable given as T respectively.
The set of equations in (5.1) shows that deriving one quantity allow one
to derive the other. For example, knowing the survivor function allows one to
calculate the hazard. The hazard function (h(t)) is the quantity most of inter-
est in this thesis as will be seen. The hazard provides the risk an individual
face at a given time. Survival analysis is primarily concerned with identify-
ing these functions in the presence of censored observations. The nature of
censoring and the different types of censoring will be discussed next.
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5.2.1 Censoring
Censoring relates to when the response variable is not fully observed. For
example, in the BCa data, all the patients have entry points (i.e. when they
were diagnosed as having BCa i.e disease specific mortality (DSM)) but not
all have an exit point (when they died from BCa). Some patients were ‘lost’
during follow-up and one is only aware of the last recorded time of follow-
up. Also, some patients (38%) died from other causes (this is known as the
other cause mortality (OCM)). These groups of patients are also considered
censored since they DID NOT die from BCa and it is impossible to know the
BCa death times since it is impossible to die twice. Fig. 5.3 illustrates this
point.
Mathematically, one assumes that there are two type of times for the pa-
tient (i). The censored time (Ci) and the event time (Di) but only one




Di if Di ≤ Ci
Ci if Di > Ci
(5.2)
Survival analysis techniques allow to model the event times (even if not
observed) from the censored observations. In essence, they allow one to an-
swer the following question: What would have been the time of death from BCa
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20 40 60 80
Figure 5.3: Illustration of censoring. The event times of patients B and D
are not known since the study ended before they could be observed. Only
their censoring times are known. Patients A and F have their event times fully
observed as they died from the event of interest at approximately 40 and 75
months respectively. However, the event time of patient F is about 30 months
since the patient entry point is about 45 months after the study started. This
phenomenon whereby patients do not enter the study at the same time is
known as staggered entry [120][154]. Patient C withdrew from the study at
40 months (censoring time is 20 months) while patient E was lost to follow-up
at 40 months (censoring time is 50 months).
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for a patient who is known to have survived past 3 months after being diagnosed
but whose event time is not known?. Some questions arise naturally when
analysing survival data. Why not just remove the censored observations? Or
why not treat censored observations as event times (i.e. set Ti = Ci∀i, δi = 0
)? As noted in [154], this is not ideal. In many survival studies, the number of
censored data points are typically more than non-censored ones (79.8% cen-
sored in the BCa data) which may result in the removal of vital data points,
thus resulting in biased models. Setting Ti = Ci is even more flawed as illus-
trated in Fig. 5.4.
There are three broad categories of censoring namely:
1. Right Censoring: This censoring type has already been described
and is the most common in medical studies. It occurs when the
event time is known to exceed a particular time.
2. Interval Censoring: This is a situation where the event time is
known to fall within a particular interval. This type of censoring
is common when there has been a rounding of times of events for
example, rounding off times of death from BCa results in interval
censored observations. However, provided that the interval is not
too large, analysis may proceed by treating the censored values as
event times with little or no loss in model accuracy.
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Figure 5.4: The blue dash line is the underlying function. The black dots are
the Gaussian corrupted measurements and the red line is the estimated func-
tion using linear regression. The blue stars are the observed censored times
for the censored observations (red dots). One observes that as the number of
censored observations increase, the elicited model becomes more biased.
3. Left Censoring: This is very rare in medical practice and occurs
when the event times are known to be below a particular time
threshold.
Only right censoring mechanisms are considered in this research study.
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5.2.1.1 Standard Techniques
Two broad frameworks for survival analysis are the Cox models and acceler-
ated failure time (AFT) models. In the Cox models, the hazard is modelled
directly. The hazard is defined as the instantaneous risk of an event and is
given in the Cox model [72] by the following equation:
hi(t,xi) = ho(t) exp(α
Txi) (5.3)
where xi represents the values of the input variables (covariates) for the ith
subject, α is the vector of parameters and hi(t,xi) the corresponding hazard
for i = 1, 2, · · ·N . N is the number of subjects under study.
Equation (5.3) simply means that the hazard of failure at any point in time
t for a subject with covariates defined by vector x is a product of two functions.
The first function is time-dependent and is called a baseline hazard (ho(t))
and does not depend on the subject’s attributes. The second function depends
only on the subject’s attribute but is not dependent on time exp(αTxi). It may
be easily deduced that the so-called hazard ratio which is the ratio of two
subjects’ hazards does not depend on time since the common time function
which they both share cancels out.
The AFT approach models the time of event directly by assuming the times
of an event and covariates act multiplicatively on this time scale. This ap-
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proach is very similar to ordinary linear regression. The general AFT model
equation is given by the following equation:
ln(Ti) = Yi = α
Txi + Zi (5.4)
where Zi is a random variable which is assumed to follow a particular para-
metric distribution. Ti is thus also a random variable that defines the distribu-
tion of event times for subject i. If one defines ψ = exp(αTx), then it is easy
to show the following:
T = ψiTo (5.5)
where T0 corresponds to the random variable of the baseline (when x =
0, T0 = exp(Z0)).
Analysis of equations (5.4) and (5.5) quickly reveals that:
S(t,x) = So(tψi) (5.6)
The interpretation of the AFT models is thus as follows: If ψi < 1, then it
appears as if the clock ticks faster for the subject with covariates (xi) when
compared with the baseline. This means that the time scale for that subject is
Toψi. Consequently, the survival time is shortened as a result of the failure be-
ing ‘accelerated’. However, if ψi > 1, by a similar argument, then the survival
time is lengthened as the consequence of failure being ‘decelerated’. For this
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reason, ψ, which is sometimes called a link function, serves as an acceleration
factor.
It is also possible to non-linearise the linear part of this this link function
using a non-linear model as has already been done in [155] using neural
networks and restricted cubic splines [156]. Other types of interpretation in
survival data modelling are also possible e.g. proportional odds [157].
Using linear models in the link functions of both the Cox model and the
AFT models have peculiar intuitive appeals, especially to clinicians. However,
in real systems especially, the assumption that the hazards are affected by an
exponentiated linear function of the covariates as given by equation (5.3) may
not be tenable and there is a reluctance in using black box non-linear models
because of the loss of this intuitiveness and interpretability. It is argued in this
thesis that by using fuzzy systems, instead, one can maintain interpretability
to allow for incorporation of subjective knowledge as well as increase model
accuracy. It will be shown in section 5.5 how the interpretability of the fuzzy
model output is not affected when incorporated into the link function. Ad-
ditionally, this output is indicative of the risk a patient faces on outset of a
disease since one is directly modelling the hazard earlier defined. Therefore,
using FLS may be a promising alternative when non-linearity is desired and
interpretability is to be maintained. This is illustrated by means of an artificial
119
5.3. Kaplan-Meier - Non Parametric on the bladder cancer data
data and the BCa data. However, it is instructive to first analyse the BCa data
using the standard survival techniques as presented in succeeding subsections.
5.3 Kaplan-Meier - Non Parametric on the bladder
cancer data
It is worth investigating what information can be drawn from the BCa data
using the Kaplan-Meier estimator 2. As mentioned in chapter 2, this estimator
is most widely used for analysing homogeneous survival data. In the BCa
case, the data was stratified into different categories based on sex, treatment








where ti are the times at which the events occurred, r(ti) are the number of
events at risk at time ti and di is the number of events at time ti.
If death times due to other causes are taken as censored3, then the cancer
specific mortality analysis using the Kaplan-Meier estimator of the BCa data is
as shown in Fig. 5.5. The Kaplan-Meier estimator applied to selected strata
are shown from Figs. 5.7 to 5.9.
2Also called the product limit estimator.


























Figure 5.5: Kaplan-Meier analysis of BCa deaths.
5.4 Performance Indices
Performance indices allow for comparison of modelling performances of dif-
ferent techniques. Because of the presence of censored observations, using
performance indices such as the root mean square error (RMSE) typically used
in regression or the area under the curve (AUC), the receiver operator charac-
teristics (ROC) used in classification can be challenging [158]. For this reason
new performance indices have been defined in the literature [50] but the
























Figure 5.6: Kaplan-Meier analysis of different causes of deaths.
in this thesis appears to have the best intuitive appeal because it is easy to
understand.
5.4.1 Concordance Index
The concordance index (c-index) makes use of the fact that a subject with
a high risk or prognostic index (pk), is likely to have a lower survival time
than the one with a lower prognostic index (pl). So, if pk > pl and tk < tl,
then the subject pair (pk, pl) is said to be in concordance if the assertion holds
true. The c-index is useful when one is not strictly interested in the times of























Figure 5.7: BCa sex strata Kaplan-Meier estimation.
their risk ranks as is the case in many medical studies and in this thesis. The







Where Np represents the number of unique usable pairs in the observations.
A pair is usable if and only if both survival times are observed or the subject
with the censored observation has a censored time greater than the subject














Figure 5.8: BCa age strata.
are censored. I is an indicator function which is defined as follows:
I(pk, pl) =

1 if pk > pl,
0 otherwise
(5.9)
The interpretation of this equation is that a higher risk/prognostic index indi-
























Figure 5.9: Kaplan-Meier estimation of different age strata of the BCa data.
5.4.2 Modified ROC
When the prognostic indices for the population has been found, existing meth-
ods of finding the ROC cannot be used because some observed times are cen-
sored. It is not possible in practice to know if an individual with a censored
failure time lower than the chosen threshold time (60 months in this study)
would survive past this threshold i.e. is a low risk individual. To obtain a pic-
torial performance index and to be able to use the ROC analysis, a new c-index
























Figure 5.10: Kaplan-Meier Analysis on radiotherapy treatment.
true positive TP rate). However, a pair is redefined to be usable by comparing
each calculated prognostic indices (pk) with a constant prognostic threshold
(pthresh). Finding the FP rate or theTP rate is achieved by using this new set of
usable pairs. The ROC can then be constructed in the usual iterative manner
[120]. Also, the Breslow estimator [120] allows for calculating the baseline
hazards and baseline survival functions which consequently facilitates calcu-
lating median survival times for specific covariate values. This was explored in
























Figure 5.11: Kaplan-Meier Analysis on cystectomy treatment.
the observed values in the case of the artificial data. It is worth noting that
it would be erroneous to compare the predicted median survival times with
the observed times for individuals whose failure times are censored. A better
approach would be to compare times for only those individuals whose failure
times were observed exactly (Non-censored). This thesis makes use of both
the defined c-index in equation (5.8), the proposed modified ROC analysis and
the RMSE of predicted median times and observed times for non-censored ob-



















Figure 5.12: Graphical representation of the ROC curve.
Cox-model.
Several methods exist to define the risk groups of subjects from survival
times, for example see [159]. Here, the simple approach, usually common
among clinicians, is taken in this research whereby a time frame is chosen
(typically 5 years in cancer studies), and subjects with a failure time greater
than this threshold are assumed to be low risk individuals and vice versa.
Only censored observations that has survival times greater than this threshold
may be included in the study. Nothing can be concluded on individuals with
censored times less than this time threshold. The ROC curve is constructed as
the true positive (TP) against the false positive (FP) rate as already described.
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This thesis investigates the ability of using fuzzy survival modelling results
to find risk groups on two the data sets and thereafter provide recommen-
dations for treatment therapy (one artificial data set and one real data set).
These two data sets are examined in more details in the next subsections.
5.4.2.1 Artificial Data
The purpose of this artificial data generation is to demonstrate the case where
non-linear modelling technique is needed to generate good modelling results.
The artificial data generation mechanism is similar to the one in [160]. The
data is highly non-linear and using a linear Cox model will lead to sub-optimal
modelling results as will be seen. Additionally, using the artificial data, one is
able to investigate the hypothetical scenario that one has the event times but
were censored by some mechanism. It would then be of interest to compare
the elicited model performances with the real times. The artificial data set is
generated according to the following expression:
t = (x0+x1+x2−15)2+(x3+x4−10)2+x5+(x6+x7−15)2+(x8+x9−10)2+ε
(5.10)
The x’s are the covariates drawn from uniform continuous distributions so
that they have values between 0 and 10. ε is a random value (noise) added to




, β = 0.4 for input variable noise and 2.0
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for output noise. Independent censoring was achieved by randomly choosing
50% of the data set and randomly drawing a uniform number from 0 to the
event times of each the chosen data points. Two thousand (2000) data points
were generated via MATLAB R© 2015a software for training and 1000 were used
for testing. The artificial data set allows for a hypothetical scenario where one
knows the exact failure times of the censored observations (an information
one is not privy to in real life situations). The model is trained as discussed
using the censored times and the event times of the uncensored observations.
One can then investigate how the predicted median times (a function of the
prognostic index and baseline hazard) compare with what would have been
the event times had they not been censored. The RMSEs between the pre-
dicted median values and event times were used for this comparison in this
study. As already stated, the k-fold cross validation was used to select optimal
number of fuzzy rules which was found to be 17. Fig. 5.13 shows the plot
of the artificial data for two input dimensions (x0 and x1) against the output
dimension which is time t. The other input variables are set equal to 5 to
show the non-linearity of the data at these values. Fig. 5.14 shows the data
distribution of the times and one input variable (xo).
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Figure 5.13: Plot of two input variables (x0 and x1) for the artificial data to
display non-linearity. The other variables were set equal to be equal 5.
5.5 Proposed New Method for risk Prognostics
5.5.1 Modelling Framework
It is proposed to integrate the traditional Cox model with fuzzy systems mod-
elling such that the linear part of Cox model is replaced with a flexible fuzzy
model. The elicited model is thus able to infer risk groups (low risk or high
risk) in a non-linear intepretable fashion from a survival data. Using the haz-
ard for this subdivision is thus natural; A high risk/hazard indicates lower
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Figure 5.14: Histogram of simulated times and one input variable (x0). The
times in this case are the real times and not the censored times.
failure time4. From equation (5.3), the link function, λ, which is also taken
to be the prognostic index p, is taken to be the exponent of the output of the









λ. λ is the link function, Si(t) is the survival time of individual i and S0(t) is
the baseline survival function. Since S0(t) < 1 ∀ t, higher value for λ i.e. higher risk/hazard
and lower survival time.
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where f jFLS(xj ,α) is the output of the FLS with parameters α for individual
with covariate values xj . λj is the prognostic index of the individual. It can
easily be shown that since λj is mapped from the output space of the fuzzy
model using a monotonic function (exp), then according to Zadeh’s extension
principle [127], the the membership function is maintained as a result of
the one-to-one mapping caused by the monotonic transformation. This will
ensure that interpretability is maintained since a linguistic value of the output
space maintains the same linguistic value (e.g high, low) in the transformed
space.
Lemma. Consider two universes of discourse X and Y , and a monotonic func-
tion y = f(x), then a fuzzy set A in X has same interpretation with image of B
in Y , such that B = f(A).





So that the same MF (f is a one to one mapping) is retained in B and conse-
quently has the same interpretation. 
Therefore, it can easily be seen that interpretability is not lost as long as
the function is monotonic (an exponential in this study). Fig. 5.15 shows a
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Figure 5.15: Schematic diagram of the proposed modelling framework. The
first stage consists of building an interpretable model that classifies a patient
as a low or high risk. The elicited models have implicitly added the treatment
decisions (if any) which can help proffer the type of treatment in the second
stage.
schematic diagram of the proposed modelling framework. The output of the
fuzzy model, as previously discussed, is a prognostic index that is indicative of
the degree of risk a patient has. This prognostic index can be combined with
prior expert information so that a treatment decision can be made to lower
the prognostic index and thus recommend a risk management decision.
5.5.1.1 Training the Model
In survival data modelling with right censored observations, one observes the
data of size N and a triple (Tj , δj ,xj), j = 1, · · · , N , where Tj is the time
observed for individual j, δj ∈ {0, 1} is an event indicator (δj = 1 means
event times Tj are observed directly, δj = 0 represents a situation where event
times Tj are censored.) for individual j. Estimation of parameters is usually
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carried-out by maximizing an objective function such as the c-index [160],
area under the survival curve [50], partial likelihood [161], etc.
The fuzzy model is trained according to the partial likelihood methodology
given in equation (5.14) which is based on the same premise of the orignal
Cox model. The idea of the partial likelihood methodology is to find those pa-
rameters that ensure that a patient with a lower event time is ranked higher
(higher prognostic index) than one with a higher event time. With the unique
event times (censored times are excluded) ordered, the Cox’s partial likeli-







where R is the number of unique event times and f(xj ,α) is the output of a
FLS with parameters α for individual j with covariate values xj . nj represents
the number of individuals at risk at event time tj . This number includes the
censored individuals that have not failed at this time. The parameters of the
FLS are found by maximising equation (5.14). Optimisation of this equation
was performed using a genetic algorithm (GA). The negative log-likelihood
(NLL) of equation (5.14) was used to change the objective function to a min-
imisation problem so as to be able to use our prior designed GA software. The
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Details of the derivations of partial likelihood formula for the Cox models
from data likelihood may be found in [161, 120].
5.5.1.2 Optimisation and Validation Details
GA is an evolutionary algorithm which imitates survival of the fittest [162]
phenomenon. The procedure for optimising the survival fuzzy model is out-
lined as follows:
1. Initialise the population Np randomly. This represents Np fuzzy
models. The fitness of the population is evaluated according to
the objective function defined in (5.15).
2. Select two parents according to the tournament method [163]
where the two parents are selected in turn from the higher fitness
value of two randomly chosen chromosomes.
3. Crossover along a randomly chosen point in the genome vector is
performed with probability Pc in two selected parents to form two
offspring. With probability 1−Pc, no crossover takes place, so the
two parents are cloned to become the two off-springs.
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4. Every parameter of the FLS is subject to random mutation with
probability Pm such that αh = αh+ ζ. αh is a specific FLS parame-
ter and ζ is random Gaussian number of mean zero and standard
deviation one.
5. Both sets of parents and offsprings are reinserted into the popula-
tion pool. Np is kept constant by discarding the two chromosomes
with the worst fitness value.
6. The optimisation run is stopped whenNg generations have passed
or if change in average fitness value after each generation is less
than ε = 10−6.
Using a non-linear model, such as FLS together with GA, can quickly lead
to over-fitting of the training data set. To circumvent this problem, each data
set was divided into two. 2/3 for training and remaining the 1/3 for testing.
k-fold cross validation (Fig. 5.16) was performed on the training data sets
to select model with the best generalisation ability k = 5). The maximum
allowable number of rules was set to be 20 to manage computational time.
In the artificial data set, the fuzzy model with 17 rules was found to have the
best result based on the k-fold cross validation while the fuzzy model with 18
rules was found for the BCa data set. The testing data set was used to show
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5 fold CV on the 
Training Set
Testing Set
Figure 5.16: Data was partitioned with 33% in the test set and 66% in the
training set. In the pilot study the best performance on the training set was
found using 5-fold cross-validation.
the generalisation ability on a data set not used in the training procedure.
5.6 Results & Discussions
5.6.1 Artificial Data
Fig. 5.17 shows a comparison of the ROC performances using the Cox model
and the proposed fuzzy modelling framework on the test data set of the arti-
ficial data. With an AUC of 0.51, the Cox model is no better than a random
guess of the risk groups of patients. This is because a linear Cox model has
been used on a highly non-linear data set. The fuzzy model has an AUC of
0.76 which represents almost 50% improvement in modelling accuracy. The
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(b) Fuzzy modelling results.
Figure 5.17: Comparison of ROC performances on the artificial test data set.
Results show that the Linear model is not better than random guessing of
the risk groups while using fuzzy modelling shows promising results. Positive
means high risk (low survival time) and negative means low risk (high survival
time). The red dotted line is the y = x line. ROC curves that coincide with
this line are no better than random guesses.
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degraded modelling performance on the Cox model is not unexpected since
the generated data set is highly non-linear. The concordance index shown in
Table 5.4 gives similar result. The fuzzy model expectedly (being a non-linear
model) outperforms the Cox model on artificial data. A closer inspection of
the performance of the proposed fuzzy modelling framework on the artificial
data shown in Fig. 5.18 reveals a model that is capable of inferring correctly
both the risk groups as well as the predicted median survival times. It can
also be observed that the model (Fig. 5.18D) is also able to handle the fact
that some times were not observed directly and is able to infer correctly what
would have been the observed survival times had they not been censored.
The proposed modelling framework has been able to handle this missing data
problem.
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In contrast, as shown in Fig. 5.19, the Cox model performs very badly
using this data set and is not able to infer risk groups correctly as well as to
predict the median times.
5.6.2 Bladder Cancer Data
Fig. 5.20 shows the ROC curves on the testing data set of the BCa data using
the proposed fuzzy model and Cox model. The AUC for the Cox model is
0.83 while that for the fuzzy model is 0.91 which is an improvement on the
Cox model. The concordance index, as shown in Table 5.4, reveals that the
proposed fuzzy modelling framework provides about 13% improvement in
performance compared with the Cox model.
5.6.2.1 Therapy Recommendation
The ROC curves of Fig. 5.20 show the performance of the classfier at different
selected thresholds for the prognostic index/risk score. In practice, however,
only one value of the prognostic index is desired and values greater than this
threshold are taken to be high risk patients and vice versa. In this thesis, the
’optimum’ point is selected to represent a trade-off between FP and TP rates
using the isocost lines method. Fig. 5.21 shows the distribution of the log
of predicted prognostics indices for the testing data set of the BCa data. The
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Predicted











RMS Error =  47.436
Censored
NonCensored
(a) All Training Data (censored and
uncensored). Censored observations
are indicated by red data points. It
can be seen that the fuzzy model tries
to predict what the failure time would
be if the observation had not been cen-
sored.
Predicted











RMS Error =  23.6843
(b) Training Data (Uncensored Only).
The fact that the data contains cen-
sored variables does not affect the re-
sults of the uncensored observations.
Predicted










RMS Error =  24.6868
Fuzzy - Test Data
(c) Testing Data. The proposed mod-
elling framework is able to generalise
to unseen data. The Testing RMSE is
not so much different from the train-
ing RMSE, even though the data is
highly complex and non-linear.
Predicted Median Time














RMS Error =  33.4865
Censored
NonCensored
(d) Predicted median times vs. would
have been failure time of censored
observations. The fuzzy model does
well in anticipating what the failure
time would have been had the obser-
vations not been censored. It should
be noted that the "would have been
failure time" is not observed in real life
data. For censored observations, the
censoring times were used in training
the fuzzy model as explained.
Figure 5.18: Fuzzy Model Prediction Results on Artificial Data set. The Fuzzy
model outperforms the traditional Cox model both in terms of predicting per-
formances as well as not allowing censored observations to bias the elicited
models.
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RMS Error =  58.211
Censored
NonCensored
(a) All Training Data (censored and
uncensored)
Predicted











RMS Error =  53.9746
Cox - Training Data
(b) Training Data (Uncensored Only)
Predicted










RMS Error =  55.2293
(c) Testing Data
Predicted Median Time














RMS Error =  50.9094
Censored
NonCensored
(d) Predicted median times vs. would
have been failure time of censored
observations.
Figure 5.19: Cox Model Prediction Results on Artificial Data set.
optimum operating point (marked o in Fig. 5.20) was found to be 0.4. Patients
with prognostics indices greater than this threshold are high risks patients and
vice versa.
Table 5.2 shows the confusion matrix at the selected optimum point (
FP = 0.13 and TP = 0.74). It can be observed from this table that 167
patients are predicted to being high risk patients and 513 patients to being
low risk. From the risk groups, one patient each is selected at random for
analysis. The cystectomy and radiotherapy values as well as their prognostic
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False positive rate


























Figure 5.20: Comparison of ROC performances on the BCa test data set. Point
marked o is the optimum point based on the isocost line method.
Table 5.2: Confusion matrix at the selected optimum point.
True Class
Low Risk High Risk
Hypothesized Class
Low Risk 471 44
High Risk 64 103
indices of these two selected patients are shown in Table 5.3.
On the one hand it can be observed that where patient 1 (high risk patient
with prognostic index of 20.09) is seen to neither having undergone radio-
therapy nor having had cystectomy performed. On the other hand patient 2
(low-risk patient with prognostic index of 0.01) had cystectomy performed.
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log of prognostics index












Figure 5.21: Distribution of log of the predicted prognostics indices using the
fuzzy model (testing data).
Table 5.3: Selected patients characteristics
Cystectomy Radiotherapy Prognostic Index Observed Event Times
Patient 1 No No 20.090 (High Risk) 10.8 months
Patient 2 Yes No 0.013 (Low Risk) 133.4 months
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Further investigation of patient 1 reveals that the prognostic index reduced
to 10.090 when the cystectomy variable was changed to ‘yes’. However, the
patient still remains high-risk since the prognostics index is still above the
threshold of 0.4.
Overall, of all the patients that received radiotherapy or cysctectomy and
are in the low-risk group, 45% would have been in the high-risk group had
either therapies not been performed. Also, had either of the therapies been
performed on the high-risk group, 24% would have moved to the low-risk
group had radiotherapy been performed. Additionally, as can be observed in
the surface plots of Fig. 5.22, the fuzzy model has inferred a risk index that is
a highly non-linear function of the treatments and age if other variables are set
to the baseline (zero). A patient who undergoes radiotherapy (positive values
= treatment administered, negative values = no treatment) tends to have a
lower risk index and is typically below the threshold (log(0.4) = −0; 916),
hence in the low-risk group. Radiotherapy seems to be more effective in
younger patients. Having cystectomy performed seems to represent a more
effective treatment for older patients.
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(b) Radiotherapy and age vs log prognostic index
Figure 5.22: The figure shows how age and treatment decisions affect the
prognostic index. Negative values of treatments mean no treatment and pos-
itive values mean treatment was performed. It can be observed that radio-
therapy is more effective for younger patients. For cystectomy, the treatment
seems more effective for older patients. The threshold value for the prognostic
index, as discussed, is 0.4 (log(0.4) = −0.916).
147
5.6. Results & Discussions

































































































































(j) Input 10 (Urothelium)












(k) Input 11 (Muscle)

























(m) Input 13 (Radiother-
apy)
Figure 5.23: The figure shows a sample fuzzy rule-base. Only the first four
rules are displayed for each input dimension.
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Table 5.4: Concordance index values on the Training and Testing data sets









This chapter has extensively analysed the bladder cancer data used in this
research. A framework for risk elicitation based on integrating the Cox and
fuzzy modelling frameworks proposed in earlier chapters has been discussed.
This framework, which includes the treatments as inputs, allows clinicians to
investigate beforehand how different therapies affect the risk of death of a
patient diagnosed with bladder cancer. However, dynamic information (such
as relapse from bladder cancer) was not considered. The way this dynamic
information will be incorporated into the proposed modelling framework is




The previous chapter discussed how survival analysis and fuzzy models may
be combined to elicit interpretable and flexible risk mapping from patients di-
agnosed with BCa. Survival analysis allows for inference in a database when
censored responses are present. However, the assumption that the censored
responses should be independent must be made. In this chapter, this non-
parametric assumption and how tenable it is in the context of the BCa data
used in this research project are investigated. The role of competing risk
(the possibility of a patient dying from other causes) is also investigated in
detail in this chapter. Finally, a dynamic risk model (using the principles of
multi-state modelling and the fuzzy modelling frameworks proposed in earlier
chapters) is elicited in this chapter. The model allows to handle and incorpo-
150
6.1. Independent Censoring
rate dynamic information, such as a patient relapsing from BCa in the course
of follow-up. The chapter concludes with testing the proposed framework on
the BCa data.
6.1 Independent Censoring
It is worth investigating how the competing risk methodology could be used to
improve elicited models. The elicited model in chapter 5 assumes the indepen-
dence between censored times and event times. This is simply means that in
the hypothetical situation where both censored and event times are observed,
both times must be independent in the statistical sense i.e. the knowledge of
one does not determine the other. However as discussed in [164], when there
is a possibility of patients dying from other causes, then the independence as-
sumption is likely not valid. The independence assumption simply states that
if one removes other causes, then the risk of dying from the other remains the
same. This assumption may not be justifiable in BCa risk prognosis since it is
possible that the a patient may have died from a disease aggravated by BCa.
Competing risk analysis, as discussed in the next section, allows one to handle
such scenarios.
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6.2 Competing Risks of Bladder Cancer Data
The competing risk1 approach to modelling makes fewer assumptions than
standard survival techniques which could potentially result in increased mod-
elling performances. Competing risks help one handle cases where more than
one cause of failure is possible (Fig. 6.1). For example, in this research
project, a patient diagnosed with BCa or may die from the disease or die
from other causes2. As is common in the literature, patients dying from the
BCa have been grouped in Diseases Specific Mortality (DSM) and those dying
from other causes have been grouped in Other Cause Mortality (OCM (Fig.
6.2). In the BCa data, there are 1420 (48.66%) censored observations (lost
due to follow up), 885 (30.33%) OCM and 613 deaths from BCa (DSM).
6.2.1 Kaplan-Meier Methods on the Bladder Cancer Data
(Revisited)
In Section 5.3, the Kaplan-Meier analysis was performed on the BCa data to
find the risk of death from the BCa without accounting for covariates as well
as on different strata of the covariates. It was concluded in the same section
that this method is not fit for multidimensional data analysis such as the case
1Competing risk analysis dates back to the 18th century when Bernoulli studied the effect
on mortality rates if small pox was eradicated [165].
2All other possible causes of death have been grouped and are referred to throughout as
other causes.
152











Figure 6.1: Competing risk allows one to analyse scenarios where there is
more than one possible cause of failure which precludes the other from hap-















Figure 6.2: Only one of cause (DSM) is most times of interest with the other
K − 1 possible causes lumped into one (other causes mortality (OCM)).
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of the BCa data in this research. In this section, another problem encountered
when using the standard survival techniques (such as the Kaplan-Meier and
the Cox) is discussed. The problem is called the violation of the independent
censoring assumption.
Using Kaplan-Meier method to find OCM and DSM separately provides a
simple and intuitive way to understand this problem. The probabilities of
death from each of the causes (DSM and OCM) estimated using the Kaplan-
Meier method was shown in chapter 5 (Fig. 5.11) but presented again (in
more details) in Fig. 6.3. It should be noted that when one event is of interest,
other causes are taken as censored. For example, when finding the survival
curve for patients dying from other causes using the Kaplan-Meier method,
patients who die from BCa are taken as censored.
It can be observed from Fig. 6.3 that at 190 months, the survival func-
tion value was 0.2466 (0.7534 probability of death) for OCM and the survival
function value for DSM was 0.6828 (0.3172 probability of death). The central
criticism of the Kaplan-Meier method and indeed all other methods, which
assume independent censoring for competing risk problems, is that probabil-
ities of death from from both causes which was (0.7534 + 0.3172 = 1.0706)
is greater than 1. This does not make sense as a person who has died from
one cause will certainly NOT die from another cause. To remedy this prob-
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Figure 6.3: The Kaplan Meier Analysis for OCM and DSM.
lem, there have been some approaches introduced in the literature. These
approaches, including limitations and strengths, are presented and discussed
in the next section.
6.2.2 Approaches to Competing Risk Analysis
A number of approaches have been identified in the literature (see [166] for a
review) for handling the competing risk problem. By far the most common is
finding the cumulative incidence function (CIF) from the so-called cause spe-
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cific hazard (CSH) [83]. The CIF of cause k is defined as the (Pr(T 6 t,D =
k)) of dying from cause k before time i.e 1− CIF is different from the sur-
vival/distribution function in that it specifies a joint distribution of the cause
of event and time of event. The CSH estimates the risk of dying from a specific









1 if Ti is due to DSM
2 if Ti is due to OCM
(6.2)
where k ∈ 1, 2 which represents the different causes of death. k = 1 represents
death from BCa (DSM) and k = 2 represents death from other causes (OCM).
It becomes apparent, as shown in [83], that estimating the CSH follows
exactly the same procedure as estimating the hazard in equation (5.14) where
one treats as censored events due to other causes. Therefore, estimating the
CSH for each cause simply proceeds by following the same procedure outlined
for estimating the hazard in Chapter 5. The hazards (CSH) is still relevant and
may be used as the risk of death as described in Chapter 5. Causes not of in-
terest are simply treated as censored variables. However, calculating the CSH
allows to glean out more useful information from the data e.g. by calculating
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the CIF.
















S(t) is the overall probability no failure from ANY cause at time t.
As in chapter 5, the non-parametric approach to estimating these quan-
tities is usually favoured since they make less assumptions than parametric
methods about the distribution of the data.
6.2.2.1 Using the Cumulative Incidence Function as risk estimates
The CIF makes use of both the risk of death from BCa as well as the risk
of death from other causes which could potentially lead to a more accurate
modelling. The CIF risk framework is shown in Fig. 6.4 with the prognostic
indices (derived in chapter 5) serving as inputs to the framework. The reason
for this can be seen in equations (6.3) and (6.5) where it can be seen that
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Figure 6.4: CIF risk framework.
the CIF of a particular cause of death is not only dependent on the CSH of
the particular cause but also on the the CSHs of other causes. The output is
the CIF for the BCa patient with the baseline shown in Fig. 6.5. The baseline
represents the scenario where all the covariates have values of zero.
In contrast to Fig. 6.3, Fig. 6.5 has probabilities whose sum is less than 1
which is more sensible.
For a particular patient with covariate values given by the vector x, the
prognostic index is calculated discussed in chapter 5 so that the cause specific
prognostic index is given as follows:
λk(t|x) = λk0(t) exp(fkFLS(αk,x)) (6.6)
where fkFLS is the fuzzy model for cause k having parameters αk for a patient
with covariate values x.
The CIF can now be calculated as given by equation 6.3.
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Figure 6.5: CIF function baseline for both BCa and other causes. The baseline
indicates that patient with zero values for covariates (for example, no cystec-
tomy or radiotherapy, zero years) has about 30% chance of dying from BCa at
60 months.
As in Chapter 5, the risk of patient may be found by taking a time point (60
months in this study) and patients with CIF values greater than a threshold
considered high risk while those with lower CIF values than the threshold
considered low risk. By varying this point, the ROC curve may be plotted as
discussed in chapter 5. The same training and testing data division used in
chapter 5 were used in this section and the same training procedure followed.
The ROC curve of using the CIF as the risk determinant is shown in Fig. 6.6. It
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Figure 6.6: ROC on the test data using the CIF method.
can be seen from the figure that by adequately handling competing risk, there
has been an increase in modelling accuracy of about 2%.
6.3 Multistate-Fuzzy Modelling Approach
The BCa data contains some vital information which were recorded during
follow up of the patients. For example, 1477 (50%) patients were found to
relapse from the disease during the course of managing the disease. This new
information may significantly affect the risks (prognostic indices) calculated
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Figure 6.7: BCa multistate model. The BCa patient could be be seen as po-
tentially moving from states to states. State 0 is living with the BCa disease,
state 1 is having a relapse from BCa after undergoing initial treatment, state 2
is the OCM and state 3 is dying from BCa (DSM). The arrows indicate possible
transitions between states. States 2 and 3 are usually called absorbing state
since transition out of the two states is not possible i.e. a dead person can no
longer be diagnosed with BCa.
in Chapter 5. To handle this, it is often desirable to consider the patient as
moving within states as Fig. 6.7 illustrates.
A patient who has just been diagnosed with Bladder Cancer and has un-
dergone therapy moves into state 0. The therapy recommendation could be
as obtained in chapter 5 or via some other mechanism. This patient has three
possible course which are: relapse from the disease (move into state 1), die
from Bladder cancer (state 3) or die from causes unrelated to BCa (move into
state 2), this is illustrated in Fig. 6.8.
A patient whose BCa is back is known to have significantly worse prog-
nosis and death almost inevitably results even with aggressive therapy. This
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Figure 6.9: Transitions from State 1
modelling framework allows one to model such scenarios. At state 1, the pa-
tient could transition to state 2 (die from other causes) or state 3 (die from
BCa), this is illustrated in Fig. 6.9.
Transitions out of state 2 and 3 are not possible since they are considered to
be absorbing states. It turns out that this approach to dynamic risk modelling
is similar to the competing risk scenario introduced in the last section (see
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[164] and [83] for extensive details). Consider a patient who has just been
diagnosed with BCa and consequently in state 0. Because this is a competing
risk modelling problem, the associated analysis may proceed as described in
section 6.2. Therefore, one would have three CSHs: λ01, λ02 and λ03.
A patient that enters state 1 (the relapse state) may move into either state
1 or 2 as already stated. This is also a competing risk modelling problem but
the patient is only considered after having entered state 2. Two CSHs result:
λ13 and λ12 will be estimated. All other CSHs are zero as transitions to and
from these states are not possible3. The analysis proceeds, again, as described
in section 6.2.
In summary, five different CSHs are calculated each providing a prognostic
risk index of moving from one state to another. Distribution of the prognostic
indices are shown in Figs. 6.10 - 6.14. A higher prognostic index indicating a
high risk of transition between the states in question.
6.3.1 Discussion and Analysis
This section analyses how the risk prognostic indices are affected by age. Figs.
6.15 - 6.19 show how the risk of moving states are affected by age. The risk
of moving from initial state) to the relapse state seem to decrease as one
3Which is logical since the risk of moving from dying from BCa state (State 1) to say relapse
state (state 3) is impossible.
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risk prognostic index











Figure 6.10: Transition from state 0 to 1 risk prognostic index (log).
progresses with age. This may be due to the fact that there are older patients
who have a higher risk of death than just relapsing from the disease as shown
in Figs. 6.16 (moving from initial state to dying from other causes) and 6.17
(moving from initial state to dying from BCa). Therefore, younger patients


















Figure 6.11: Transition from state 0 to 2 risk prognostic index (log).
6.4 Summary
This section has provided a mechanism for incorporating dynamic informa-
tion during bladder cancer patient’s follow-ups. Specifically, the proposed
method uses a multistate modelling approach where patients who relapse are
assumed to have entered into a new state. This approach allows the static
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In this research, new frameworks for understanding the risk of death after
a patient has been diagnosed with bladder cancer (BCa) through the use of
interval type-2 fuzzy logic systems (IT2 FLSs) has been proposed.
The thesis starts by proposing a new method to elicit interval type-2 fuzzy
models from data. The approach presented is based on the interval type-2
fuzzy clustering algorithm. The proposed method allows one to systemati-
cally determine the antecedent and consequent parameters of the IT2 FLS be-
fore a gradient-based optimisation algorithm is derived to further tune these
parameters in a bid to elicit more accurate fuzzy models. This is a shift in
conventional IT2 FLS parameters initialisation where they are in most cases
randomly initialised. This systematic and elegant initialisation leads to better
174
accuracy and improved performance of subsequent optimisation stages.
Tested extensively on synthetic and artificial datasets, the proposed frame-
work outperforms existing neuro-fuzzy modelling frameworks of a similar
type in both prediction and generalization capabilities.
To overcome the limitations of the existing fuzzy modelling technologies
to handle random uncertainties in the data modelling process, the research
proposes the incorporation of Bayesian modelling with fuzzy modelling. This
approach was shown to be able to handle random uncertainties and provide
accurate predictions with confidence bands.
The BCa database has been analysed extensively in Chapters 5 and 6. A
new framework which involves the integration of the Cox modelling approach
with the interval type-2 fuzzy logic system approach has been proposed. The
aim of this integration strategy is to take advantage of the simplicity and math-
ematical convenience of the traditional Cox modelling framework and the in-
terpretability and non-linear modelling capabilities of interval type-2 fuzzy
models. This synergistic modelling architecture has been used to predict the
prognostics index of an individual diagnosed with BCa which is indicative of
the level of risk. The higher the prognostic index, the higher the risk and
vice versa. The different treatments administered have been used as input
variables to the predictive model in order to allow the clinicians determine
175
7.1. Future Recommended Work
how such therapies have affected the prognostic index so as to manage risk.
With an Area under receiver operating characteristic curve of 0.93, the pro-
posed modelling framework has outperformed the traditional Cox model and
artificial intelligence methods such as the neural network.
In the concluding parts of the thesis, the proposed modelling framework
has been extended so as to be able to handle dynamic information (such as re-
lapse from BCa during follow-up). The approach generalises the fuzzy model
elicited in earlier chapters by using the multistate modelling principle whereby
patients are taken to move from one state to another during follow-up.
7.1 Future Recommended Work
As a result of the studies presented in this thesis, the following future research
recommendations can be made:
1. The interval type-2 fuzzy modelling approach used throughout
this thesis is a simplification of the more general type-2 fuzzy
models. The general type-2 approach allows for more degrees
of freedom in fuzzy models but are very computationally taxing
as discussed in the thesis. How to reduce this computational bur-
den is an evolving research area and it would be interesting to
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see how the general type-2 approach can be used instead of the
interval type-2.
2. To incorporate patient’s dynamic information, a multistate mod-
elling approach has been used in this thesis. Specifically, the
Markov assumption has been made to simplify analysis. Future
work should consider relaxing this assumption (such as semi-Markov
or non-Markov) which may allow for a more accurate incorpora-
tion of dynamic information. Additionally, it would be interesting
to apply the Bayesian approach proposed in chapter 4 to the fuzzy
modelling frameworks proposed chapters 5 and 6 in a bid to quan-
tity and manage the uncertainties in the modelling process.
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